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The word mycotoxin comes from the Greek words myco meaning fungus 
and toxicarious meaning poison (Stearn, 2004).  Mycotoxins, toxic secondary 
metabolites produced by fungi, enter the food chain through feedstuffs (Betina, 
1984).  The Council for Agricultural Sciences and Technology estimates that 
mycotoxins cause economic losses of up to 1.66 billion US dollars per year 
(CAST, 2003).  Of these fungal toxins, the trichothecene mycotoxin, T-2 toxin, is 
among the most virulent (Leeson S. et al., 1995).  Although a number of fungal 
genera are capable of producing trichothecenes, Fusarium is the most common 
(Ueno, 1983).  T-2 toxin occurs worldwide, but preferentially grows in cold, wet 
climates (Joffe, 1986).  However, free trade of cereals and grains among nations 
has allowed climatic restrictions of mycotoxins to become obsolete.   
T-2 Toxin Structure 
Trichothecenes can be divided into two groups: macrocyclic and non-
macrocyclic.  All are characterized by a 12,13-epoxytrichothecene  
skeleton, and attached side chains differentiate each trichothecene (Bamburg et 
al., 1968).  The macrocyclic and non macrocyclic mycotoxins are differentiated 
by the presence of an ester or ether-ester bridge connecting C-4 and 15 on 
macrocyclic type trichothecenes that is absent in non macrocyclic types.  
Additionally, non-macrocyclic trichothecenes are divided into 2 subgroups: Type 
A and B.  In this instance, the structural difference exists in the presence of a 
conjugated carbonyl group at the C-8 position on Type B trichothecenes which is 
absent in Type A trichothecenes (Leeson et al., 1995).  T-2 toxin, 8α-(3-
 3
methylbutyryloxy) 4β, 15diacetoxyscirp-9-en-3α-ol, is a non-macrocyclic, type A 
trichothecene.  Figure 1.1 shows the primary toxic component of T-2 toxin, like 
other trichothecenes, is the 12, 13-epoxytrichothecene skeleton followed by a 
double bond between C9 and C1 (Grove and Mortimer, 1969).  Other examples 
of Type A trichothecenes include HT-2 toxin and diacetoxyscirpenol, while Type 
B trichothecenes include fusarenone, deoxynivalenol, and nivalenol. 
Yoshizawa and coworkers (1980a) described the biotransformation of T-2 
toxin in rat liver and the gastrointestinal tract.  They found that T-2 toxin was 
quickly hydrolyzed to produce HT-2 toxin, which was then hydrolyzed to T-2 
tetraol.  In vitro trials using protein synthesis inhibition assays showed the toxicity 
of T-2 toxin and its derivates are, in order from greatest to least, T-2 > HT-2 > T-2 
triol > T-2 tetraol > acetyl T-2 (Thompson and Wannemacher, 1986).  Babich and 
Borenfreund (1991), using a human hepatoma cell line, found supporting 
evidence for this order of toxicity.   
Historical Perspective 
Mycotoxin poisoning has been documented in humans for centuries.  During the 
14th, 15th, and 16th centuries in Modern Europe people suspected of being 
bewitched, displayed symptoms of tremors, paralysis, spasms, seizures, 
permanent muscle contraction, hallucinations, manias, panics, depression and 
onset of gangrene.  These neurological symptoms are characteristic of ergot 
poisoning, a mycotoxin produced by the fungus Claviceps purpurea  and suggest  
those persecuted as witches might simply have been victims of mycotoxin 
  
12, 13 epoxytrichothecene ring 
Double bond 
between C9 & 
C10 
 
Figure 1.1  T-2 toxin structure.  Toxic components are denoted by the double 
bond between C9 and C10, as well as, the 12, 13 epoxytrichothecene ring. 
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poisoning (Matossian, 1989; Leeson et al., 1995).  Similarly, Schoental (1983), 
suggested that Mozart’s death was attributable to mycotoxin exposure due his 
poor nutritional status near the end of his life in the 18th century.  Schoental 
(1980) also proposed that the connection between bowel cancer and beer intake 
was due to the use of moldy grains in the production of alcoholic substances.  
Specific to T-2 toxicosis: during the 1930s and 1940s the Soviet Union was 
affected by Russian Endemic Panmyelotoxicosis. The disease was officially 
called Alimentary Toxic Aleukia (ATA; Kimura et al.) and has been associated 
with Fusarium infected gain containing T-2 toxin (Mayer, 1953).   
ATA is a potentially fatal disease that develops in four stages.  The first 
stage, showing the caustic nature of T-2 toxin, involves inflammation of the 
tissues that come into direct contact with the toxin.  Gingivitis, gastritis, glossitis, 
and esophagitis ensue, followed by nausea, vomiting, and diarrhea for a period 
of three to five days.  In the second stage, or incubation phase, symptoms 
subside for two to eight weeks depending on individual resistance.  During this 
time, T-2 toxin exerts a degenerative effect on bone marrow, and eventually 
leads to hemorrhagic syndrome, characterized by the appearance of 
hemorrhagic spots on the skin.  At this point, a transition occurs to the third stage 
of marked sickness characterized by complete deterioration of the bone marrow 
resulting in agranulocytosis, necrotic angina, hemorrhagic diathesis and sepsis.  
Fever develops, necrosis extends the entire length of the gastrointestinal tract, 
and lymph nodes swell.  If symptoms are diagnosed accurately, death may be 
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evaded.  In the period of recovery, or fourth stage, necrotic and hemorrhagic 
symptoms may begin to diminish within two weeks, while it may take up to two 
months to repair the damage to the bone marrow (Mayer, 1953).   
Biochemistry and Metabolism 
On the molecular level, T-2 toxin inhibits protein and DNA synthesis 
similarly.  T-2 toxin’s effect on RNA synthesis is less extreme (Jeffery et al., 
1984).  T-2 toxin inhibits proteins synthesis by interacting with peptidyl 
transferase located on the 60S ribosomal subunit (Wei et al., 1974).  Peptidyl 
transferase is responsible for creating the first peptide bond during initiation, but 
is also required for all additional steps of elongation (McLaughlin et al., 1977).  T-
2 inhibits each step differently in a dose-dependent manner.  At low 
concentrations, T-2 will initially stimulate initiation. However, after the first round 
of synthesis, further synthesis will be blocked.  At high concentrations, T-2 will 
terminate all steps of protein synthesis (Murthy et al., 1985).   
T-2 exerts additional effects by acting at the cellular level.  Cells most 
vulnerable to the action of trichothecenes are proliferative cells that contain a 
larger number of free polysomes found in their cytoplasmic matrix.  Regenerative 
tissues of this type include those of hemopoietic organs, lymphoid, intestinal 
crypt, and cells in the bursa of Fabricius (Terao, 1983).  
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Laboratory Animals 
In rodents, a great amount of information is available concerning the 
effects of T-2 toxin which has been shown to support cancer growth, and affect 
the immune and endocrine systems.  Mice fed a diet containing 20μg/g dry diet 
for six weeks exhibited reduced growth, reduced food consumption, hypoplasia 
of bone marrow and splenic pulp, gastritis, and dermatitis (Hayes et al., 1980).     
Carcinogenic and Cytotoxic Activity 
In mice, Corrier and Norman (1988) showed carcinogenic effects in 
animals intragastrically challenged with T-2 toxin for either 5 days at 2mg/kg 
body weight (BW),  or once at 4 mg/kg BW.  In the following 1 to 2 days post-T-2 
toxin challenge, mice were inoculated with tumor cells.  T-2 treated mice from 
each dosing regime displayed increased frequency of tumor development, as 
well as, significantly larger tumors when compared to controls.  In a 16 month 
study, male mice fed 0, 1.5, or 3.0 parts per million (ppm) T-2 toxin developed 
benign pulmonary and hepatic tumors (Schiefer et al., 1987).  In other studies, 
the liver was predominantly affected, with abnormal changes reported within 24 
or 48 hours following oral gavage (2 mg/kg BW T-2 toxin dose;  Mollenhauer et 
al., 1989).  Histological changes were seen intracellularly within the endoplasmic 
reticulum heptocytes, necrotic cells within the intestine, and loss of intestinal 
microvilli.  By day 7, 9, or 12 post-challenge, markedly affected organs were 
returning to normal, indicating clearance of the toxin.   
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Similar to mice, T-2 toxin has been shown to have carcinogenic and 
cytotoxic effects in rats.  Schoental and coworkers (1979) reported that rats 
developed brain and gastrointestinal tract tumors, cardiovascular lesions, and 
gastric hyperkeratosis an average of 22 months after receiving up to 8 once-per-
month doses of T-2 toxin (0.2 to 4.0 mg/kg of BW).  An in vitro study using lung 
tissue, report that 0.1 μM T-2 toxin was cytotoxic to rat alveolar macrophages.  T-
2 toxin reduced cell viability and cell numbers, decreased cell volume, caused 
chromium release in a dose dependant manner, and caused morphological 
changes that led to cell lysis (Gerberick and Sorenson, 1983).   T-2 toxin also 
caused lysis of red blood cells.  Rat erythrocytes were incubated with increasing 
doses T-2 toxin ranging from 2.5x10-4 to 7.5x10-4 M for 4 hours.  Results 
indicated that T-2 toxin caused hemolysis in a dose dependent manner (Segal et 
al., 1983).   
Immunological Effects 
 T-2 toxin has been shown to both enhance and suppress the immune 
system.  In mice, a single 3mg/kg BW T-2 toxin dose was associated with short 
term mastitis resistance after inoculation with pathogenic bacteria.  Mastitis 
resistance occurred 6 hours after T-2 toxin challenge when mice were inoculated 
with Escherichia coli and Staphylococcus aureus (Cooray and Jonsson, 1990). It 
was proposed that T-2 toxin stimulated macrophage cells, and caused immune 
system activation to fight the infection.  However in a long term trial, Tai and 
Pestka (1988) showed that administration of T-2 toxin caused decreased 
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resistance in response to Salmonella typhimurium.  Increased mortality was 
observed in mice first inoculated with Salmonella typhimurium and then treated 
with 1 mg/kg BW T-2 toxin every other day for 3 weeks.   Cooray and Johnson 
(1990) gave a single 3mg/kg BW dose, while Tai and Pestka (1988) challenged 
with 1 mg/kg BW every other day for 3 weeks.  The levels at which T-2 toxin was 
administered, duration of the studies, and whether treatment was either pre or 
post-bacterial inoculation contributed to these differences.   Since both gram 
negative and gram positive bacteria were used, the type of bacteria did not 
appear to affect susceptibility.     
Decreased resistance of T-2 toxin treated mice to Listeria monocytogenes 
was attributed to T-2 toxin’s effect on reducing the population and function of T-
lymphocytes and macrophage cells, and subsequent migration into sites of 
infection (Corrier and Ziprin, 1987).  At low concentrations, T-2 toxin activated 
MAPKs (mitogen activated protein kinases) which regulate cell proliferation and 
apoptosis (Yang et al., 2000).  Activation of immune cell apoptosis by T-2 toxin is 
thought to be through up regulation of MAPKs.  Similarly, T-2 toxin caused a 
suppression of the immune response to viral challenge.  Li and coworkers (2006) 
used respiratory enteric orphan virus (reovirus) as a model for viral infection.   
Balb/C mice were injected intraperitoneally with 1.75 mg/kg BW T-2 toxin and 2 
hours later were instilled with intranasal reovirus.  T-2 toxin suppressed reovirus 
clearance from the lung and increased reovirus-induced pulmonary damage.  In 
bronchial alveolar lavage fluid (BALF), neutrophil and lymphocyte numbers were 
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elevated on days 3 and 7 following T-2 toxin exposure, but macrophage numbers 
were elevated only 7 days post challenge.  T-2 also altered cytokine production 
in BALF at day 3 and mucosal IgA at days 9-10 post instillation.  T-2 toxin 
prevented clearance of the virus by suppressing leukocyte numbers, up 
regulating interleukin 6 (IL-6) which down regulated IFN-γ (interferon γ), and 
down regulated reovirus-specific IgA production.  As previously discussed, 
Corrier and Norman (1988) suggested that along with the immunosuppressive 
effect of T-2 toxin to infectious disease, T-2 toxin could also render animals more 
susceptible to tumor growth. 
Humans 
Due to the lethality of T-2 toxin, little research has been performed in 
human subjects.  Recently, T-2 toxin along with multiple other mycotoxins, was 
found in corn samples in the People’s Republic of China where high instances of 
esophageal cancer have been reported (Chu and Li, 1994).  Although the 
correlation between T-2 toxin exposure and cancer in humans seems unclear, 
studies in rodents have reported formation of tumors paralleling T-2 toxin 
administration (Schoental et al., 1979; Schiefer et al., 1987).  An outbreak of 
mycotoxicosis in Kashmir Valley, India in 1987 was traced to trichothecene 
containing bread made from moldy grains.  Twelve of 24 wheat samples were 
found to contain Fusarium mycotoxins and T-2 toxin was found in 5 of the 24 
wheat samples.  Winter temperatures in India vary from 0 to 25ºC.  When this 
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was coupled with unseasonal rains in 1987, it allowed for trichothecene growth 
and the subsequent outbreak of widespread mycotoxicosis (Bhat et al., 1989).   
T-2 toxin has also been found in milk.  Milk from Holstein cows treated 
with the equivalent of 50 ppm T-2 toxin for 15 days, had detectable 
concentrations of T-2 toxin, which was reported to be between 5 to 10 parts per 
billion (ppb;Robison et al., 1979a).   
Conceivably, indirect exposure to T-2 toxin may occur as a consequence 
to consumption of contaminated eggs or organ parts.  Chi and coworkers (1978a) 
reported toxin passage to the egg in chickens feed a 0.25 mg/kg BW T-2 toxin.  
T-2 toxin cleared from within the egg within five days.  Additionally, Chi and 
coworkers (1978b) found passage into muscle, skin and bile 12 hours following a 
0.5 mg/kg BW tritium labeled T-2 toxin dose.  The amount of T-2 toxin and its 
metabolites present in the muscle estimated by specific radioactivity was 6.7 μg 
T-2 toxin per 100 g tissue 12 hours post challenge which is equivalent to 67 ppb.  
They estimated that 1 kg muscle would contain 67 μg T-2 toxin and consumption 
of this amount T-2 toxin would not cause negative effects (Chi et al., 1977a; 
Weaver et al., 1978). These studies show that T-2 toxin can pass into the human 
food chain via egg, meat, or milk.  Pestka (1995) suggested that human 
consumption of mycotoxin contaminated meat was more likely to cause long term 
heath problems than acute toxicosis.  
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Biological Warfare Agent  
Mycotoxins have the dubious distinction of being able to cause large 
scale, detrimental effects to humans when used as biological warfare agents 
(Stark, 2005).  They show potential as warfare agents because once symptoms 
of exposure are evident; the avenue of escape is past.  Lack of explosion, odor, 
or availability of a detection system make mycotoxin intoxication particularly 
dangerous  (Stark, 2005).  Mycotoxin use was suspected during the Middle East 
War, Desert Storm.  Simon and Rea (2003) used brain imaging to compare 
mycotoxin exposed subjects, control subjects, and subjects impaired from 
exposure to toxins during Desert Storm.  Results showed similarities in brain 
scintigrams significant enough to justify further examination.  Further 
speculations suggest that The Soviet Union used “yellow rain” on the countries of 
Afghanistan, Laos, and Cambodia during the cold war, and T-2 toxin has been 
implicated as a component of “yellow rain” (Ember, 1984; Wannemacher and 
Wiener, 1997) Samples from the environment and victims near the sites of 
chemical attacks revealed traces of T-2 toxin (Mirocha et al., 1983).  In another 
report, T-2 toxin was found in samples of yellow residue scraped from plants 
growing near the Phou Bia area in Cambodia in March of 1981 (Rosen and 
Rosen, 1982). 
Occupational Hazards  
T-2 toxin and other mycotoxins pose a threat to agricultural workers who 
may be exposed through inhalation of infected grains during harvest and milling.  
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Mycotoxins have been found at levels of 130 ppb in dust particles of corn, and at 
higher concentrations in particles of less that 11 μm in diameter (Sorenson et al., 
1981).  As discussed earlier, T-2 toxin has been shown to be cytotoxic to rat 
alveolar macrophages in vitro (Gerberick and Sorenson, 1983).  In vivo, the 
toxicity of T-2 toxin has been shown to increase twenty fold when administered to 
rats via inhalation verses intraperitoneal administration (Creasia et al., 1990).   
Poultry 
Poultry suffer some of the greatest losses caused by trichothecene 
exposure because of their heightened sensitivity (CAST, CAST, 2003).  Chi and 
coworkers (1977b) reported the average lethal dose to kill 50% of animals (LD50) 
after one exposure was 5.14 mg/kg BW for day old chicks, and 4.97 mg/kg BW 
for 8 week old chicks.  However, the LD50 for laying hens was 6.27 mg/kg BW T-
2 toxin showing that young and growing chicks are more sensitive to T-2 toxin 
than adult chickens.  Other species are similarly affected, with the LD50 values 
near that of chickens (Table 1).  Bobwhite quail are 3 to 5 fold more resistance to 
T-2 toxin than other birds and laboratory animals.   
T-2 toxicosis in poultry can be characterized by several physical 
symptoms.  The first sign of which is oral lesions.  Wyatt and coworkers (1972) 
observed oral lesions in day old chicks fed diets containing 0, 1, 2, 4, 8, and 16 
μg/g diet T-2 toxin.  Oral lesions developed within one week and were yellowish-
white in color and caseous in texture.  Over the next 2 weeks the oral lesions 
Table 1. 1 LD50 Values of T-2 Toxin for Various Species 
 
Species LD50 Value (mg/kg) 
8-Week Old Broiler Chicks 4.97 Oral (Chi et al., 1977b) 
Laying Hens 6.27 Oral (Chi et al., 1977b) 
Pigeons 1.7 Oral (Fairhurst et al., 1987) 
 Bobwhite Quail 14.7 Oral (Kerston, 1998) 
Rats 3.71 Oral (McKean et al., 2006) 
 
increased in size and spread over the mouth (Wyatt et al., 1972).  Doses of 4, 8, 
and 16 μg/g diet induced neural symptoms including abnormal positioning of 
wings, hysteroid seizures, and impaired righting reflex in chicks fed T-2 toxin 
from 1 day of age (Wyatt et al., 1973).  Egg production was also affected by T-2 
toxin.  Hens fed a diet containing 8 ppm diet T-2 toxin produced fewer eggs with 
thinner egg shells.  Hatchability of fertile eggs was 20 % less when compared to 
controls, and feed consumption was depressed as a result of T-2 toxin 
consumption (Chi et al., 1977c). 
Chi and coworkers (1978b) challenged broiler chicks orally with 0.5 mg/kg 
BW tritium labeled T-2 toxin.  Samples taken 0.5 to 48 hours post challenge 
showed T-2 toxin present in every tissue sampled 0.5 hours post challenge, with 
a subsequent peak at 4 hours except in muscle, skin, and bile which peaked 12 
hours following exposure.  T-2 toxin was found in the egg twenty-four hours 
following challenge with a single 0.25 mg/kg BW tritium labeled T-2 toxin dose.  
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Eggs (yolk and white) were found to contain, 0.7 μg T-2 toxin.  In these birds, T-2 
toxin cleared from egg white and yolk within five to seven days.  In a second 
experiment by Chi and coworkers (1978b), birds were challenged 8 consecutive 
days with 0.1 mg/kg BW tritium labeled T-2 toxin.  Radioactivity within the egg 
increased until day 3 and remained at that level until the last dose.  T-2 toxin was 
found predominantly in the white, but also in the yolk and shell of the egg.  In 
birds, dosed for 8 consecutive days, T-2 toxin had not completely cleared from 
eggs by day 11 following the initial dose (Chi et al., 1978b). 
T-2 toxin causes increased mortality in chicks infected with Salmonella.  
Chickens were fed 16 μg/g of diet and inoculated with Salmonella.  Significantly 
higher mortality was observed among birds fed T-2 toxin and inoculated with 
Salmonella as compared to those only inoculated with Salmonella (Boonchuvit et 
al., 1975).  It was proposed that as a consequence of T-2 toxin damage, 
Salmonella bacteria were able to infect the gastrointestinal tract easier 
(Boonchuvit et al., 1975).  These results were supported by Ziprin and Elissalde 
(1990).  Day old chicks were treated with two daily dose of 2mg/kg BW T-2 toxin.  
On day 6 following challenge, chicks were inoculated with Salmonella 
typhimurium.  A higher rate of mortality was observed among chicks treated with 
T-2 toxin and inoculated with Salmonella when compared to Salmonella 
inoculated controls.   
Spontaneous trichothecene poisoning in birds has been reported.  In the 
Republic of Croatia, during a particularly humid season in 2002, spontaneous 
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poisoning of Brahma chickens took place (KonjeviÄ‡ et al., 2004).  Two of 10 
chickens kept as a hobby died as a result of feed contaminated with Fusarium 
mycotoxins.  Analysis revealed the contaminated diet contained 0.7 mg/kg T-2 
toxin, 0.5 mg/kg diacetoxyscirpenol, and an unspecified amount of 
deoxynivalenol.  Necropsy revealed no oral or esophageal lesions, but 
hemorrhages were found in the stomach, as was free blood in the bursa of the 
Fabricuis.  Histopathologically, necrosis occurred in bursa of the Fabricuis, 
stomach, and gut.  Once surviving animals were returned to an uncontaminated 
diet, symptoms subsided, and no additional deaths occurred.    
In a study to determine the effects of trichothecenes on lymphoid cells of 
epithelial tissues, and the follicle-associated epithelium of the bursa of the 
Fabricius, day old chicks were injected with 5 mg/kg BW T-2 toxin.   Chicks were 
sacrificed at 15 and 30 minutes post challenge, and then hourly for the next 6 
hours.  Initially, the central region of the bursal follicle epithelium was disturbed, 
and large autophagic vacuoles containing cell debris were found in the cell 
cytoplasm.  Lipid droplets were found within the Golgi apparatus, necrotic debris 
within the intracellular space, and mitochondria were swollen.  One and a half 
hours after trichothecene administration, degeneration of lymphoid cells began in 
the central regions and then extended into the periphery of the lymphoid follicle.  
Decreased bursal weight was also observed (Terao et al., 1978) 
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Swine 
Similar to avians and rodents, pigs intubated with radioactively labeled T-2 
toxin showed tissue residues.  Following an intubated dose of 0.4 mg/kg BW 
tritium labeled T-2 toxin, T-2 toxin residues of 11.5 ppb were found in muscle, 
37.7 ppb in liver, and 61.4 ppb in kidney (Robison et al., 1979b).  Thus, dissimilar 
to the chicken model, the kidney appears to be a primary target of T-2 toxin in 
swine. 
Cats 
 Lutsky and Mor (1981) were able to produce the symptoms of Alimentary 
Toxic Aleukia in cats using T-2 toxin.  Male cats were given gelatinous capsules 
containing 0.08 mg/kg BW T-2 toxin every other day until death occurred.  Cats 
died an average of 20.6 days following their first dose.  Symptoms, analogous to 
ATA in humans, included leucopenia, hemorrhagic diathesis, agranulocytosis, 
bone marrow aplasia, and sepsis.  It was concluded, cats could be used as a 
model for studying ATA in humans. 
Multiple Mycotoxin Exposure  
Multiple mycotoxins are often found growing concurrently in the 
environment and act together synergistically.  Gigeous (1999) showed the 
concurrent growth of T-2 toxin and aflatoxin in soybeans grown in Tennessee.  
Data from North Vietnam reported corn samples containing both Fusarium and 
Asperigillus toxins (Wang et al., 1995).  Huff and coworkers (1988) investigated 
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the effects of multiple mycotoxins and reported that dietary T-2 and aflatoxin 
have additive effects.  Three week old broiler chicks were fed diets containing 4.0 
μg/g T-2 toxin, 2.5 μg/g aflatoxin, or both mycotoxins (4.0 μg/g T-2 toxin and 2.5 
μg/g aflatoxin).  Chicks fed diets containing both mycotoxins showed combined 
effects of each individual mycotoxin including decreased BW, increased organ 
weight, and decreased corpuscular volume and serum potassium levels.  In 
another study, chicks were fed a diet containing either 2 mg/kg BW ochratoxin, 2 
mg/kg BW T-2 toxin, or 2 mg/kg BW ochratoxin and 4 mg/kg BW T-2 toxin from 
one day of age to 3 weeks of age.  Ochratoxin and T-2 toxin combined showed 
additive effects including decreased BW gain; increased liver, kidney, gizzard, 
and proventriculus weight; decreased lactate dehydrogenase activity; and 
increased serum triglyceride and gamma glutamyl transferase. Results of this 
study indicated that when combined, these two mycotoxins are more toxic than 
when consumed individually (Kubena et al., 1988). 
Similar to chickens, concurrent exposure to T-2 toxin and B1 Aflatoxin 
resulted in additive effects among rats (McKean et al., 2006).  Rats were able to 
withstand a higher dose of a single mycotoxin than lower doses of two 
mycotoxins.  Among rats simultaneous dosed with 1.86 mg/kg BW T-2 toxin and 
1.36 mg/kg BW B1 aflatoxin, a 70% mortality rate was observed.  These values 
corresponded to ½ the LD50 value for each individual toxin which was 3.71 mg/kg 
BW T-2 toxin, and 2.71 BW mg/kg aflatoxin.    
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Mycotoxin Regulation 
Acceptable levels of mycotoxins in food and feed grains have been 
regulated by various agencies for many years.  Currently, 99 countries regulate 
mycotoxin levels which is a 30% increase from 1995 to 2003.  Fortunately, this 
includes about 87% of the world’s population.  In the US, the FDA (Food and 
Drug Administration) has set maximum allowable mycotoxin levels in feed grains 
used for human and animal consumption as shown in Table 1.2 (Egmond and 
Jonker, 2004).  Note there are no current regulations for T-2 toxin 
Detoxification 
Different methods for mycotoxin detoxification have been studied, 
however little success has been shown.  A study was performed using two 
mycotoxin binders,  2.5 kg/ton feed of Mycofix™ (Biomin Innovative Animal 
Nutrition, Mexico City, Mexico) and 1.5 kg/ton of feed Zeotek™ (Nutek, 
Tehuacan, Mexico).   Mycofix™ was able to partially protect chickens against 
927 ppb T-2 toxin’s detrimental effects as measured by decreased body weight 
gain and decreased feed consumption.  Zeotek™ proved less effective that  
Mycofix™ which was unable to improve body weight gain or feed consumption 
among chickens were fed either toxin individually.  When 927 ppb T-2 toxin was 
combined with 567 ppb ochratoxin, greater detrimental effects were observed, 
and neither Mycofix™ nor Zeotek™ alleviated toxic effects.  Regardless of binder 
inclusion, the combined effects of concurrent exposure to T-2 and ochratoxin was  
Mycotoxin Level Product Animal type 
Aflatoxin M1 0.5 μg/kg Milk human consumption 
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Table 1.2 The United States Food and Drug Administrations Regulations for 
Source: (Egmond and Jonker, 2004)
Mycotoxins in Human and Animal Food 
Aflatoxin  
B1, B2, G1, and G2
20 μg/kg all foods except milk human consumption 
 300 μg/kg corn, peanut products, and cottonseed meal beef cattle, swine and poultry 
    
Total Fumonisins 4000  μg/kg Whole or partially degermed dry milled  human consumption 
(FB1+FB2+FB3)  corn products (e.g., flaking grits, corn grits,  
  corn meal, corn flour with fat content of   
  > 2.25%, dry weight basis)  
 30000 μg/kg Corn and corn by-products  Breeding ruminants,  
   breeding poultry including  
   lactating dairy cattle and  
   hens laying eggs 
    
Deoxynivalenol 1000 μg/kg finished wheat products  human consumption 
 10000  μg/kg grains and grain byproducts   ruminating beef and  
   feedlot cattle  
    (older than 4 months) 
   and for chickens 
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additive as measured by decreased BW gain, decreased feed consumption, 
andblood chemistry (García et al., 2003).  Hydrated sodium calcium 
aluminosilicate (HSCAS) was fed to day-old male broiler chicks in an attempt to 
decrease detrimental effects of 3.5 mg/ kg diet aflatoxins (consisting of 79% B1, 
16% G1, 4% B2, and 1% G2 aflatoxin), 8 mg/kg diet T-2 toxin, or 3.5 mg/kg diet 
aflatoxins and 8 mg/kg diet T-2 toxin until the age of 3 weeks.  HSCAS, at 0.5%, 
provided a protective effect against the aflatoxins; however no significant effect 
was seen for T-2 toxin as measured by BW gain, oral lesions, and hematology.  
HSCAC was able to avert some signs of aflatoxicosis, such increased liver 
weight, when aflatoxin was combined with T-2 toxin (Kubena et al., 1990).  In a 
similar study, Kubena and coworkers (1998) tested  the effects of T-BindTM 
(another HSCAC compound) at 0.25 or 0.375% diet against 5 mg/kg diet 
aflatoxin (consisting of 79% B1, 16% G1, 4% B2, and 1% G2 aflatoxin) or 8 mg/kg 
diet T-2 toxin on day-old male broiler chicks.  Similar to the 1990 study, T-BindTM 
did not protect against T-2 toxin as measured by decreased body weight gain, 
decreased efficiency of feed utilization, increased mortality, and increased 
occurrence of oral lesions as compared to controls.  However, at both dietary 
levels of T-BindTM (0.25% and 0.375%) the negative effects of aflatoxin was 
reduced.  Birds consuming T-BindTM had higher body weight gains and feed 
consumption, in addition to, smaller increases in liver, kidney, heart, spleen, 
pancreas, and proventriculus organ weight as compared to the aflatoxin only 
treated controls (Kubena et al., 1998).   
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In pigs, Schell and coworkers (1993) were able to show a protective effect 
against some of the negative effects of a diet naturally contaminated with 
aflatoxin.    Pigs were fed a diet containing 800 ppb aflatoxin, as measured by 
high pressure liquid chromatography (HPLC), and supplemented with various 
clays including a palygorskite, a sepiolite, a treated calcium bentonite, or 
hydrated sodium calcium alumniosilicate for 4 weeks.  Calcium bentonite, at 
0.5%, had the greatest effect against 800 ppm aflatoxin.  Pigs fed 0.5% calcium 
bentonite and aflatoxin improved ADG (average daily gain) and ADFI (average 
daily feed intake) when compared to aflatoxin controls in which ADG and ADFI 
were both decreased.  Eight-hundred ppb aflatoxin increased AST (aspartate 
aminotransferase), GGT (gamma glutamyltransferase), and ALP (alkaline 
phosphatase) levels.  Calcium bentonite, at 0.5%, prevented these increases 
when combined with 800 ppb aflatoxin.  
Chowdhury and Smith (2005) fed a diet  naturally infected with Fusarium 
to laying hens for 12 weeks and supplemented it with a 0.2% GMA (polymeric 
glucomannan mycotoxin absorbent; Mycosorb, Alltech Inc., Nicholasonville, KY).  
Mycotoxin content of the naturally infected diets was analyzed by gas 
chromatography and mass spectrometry.  Mycotoxins present in the diets 
included 12.1 and 11.7 μg/g DON (Deoxynivalenol), 0.5 and 0.4 μg/g 15-acetyl-
DON, and 0.6 μg/g zearalenone in contaminated diets and in contaminated diets 
plus GMA respectively.  GMA did not prevent decreased feed consumption, but 
increased egg production and mass during weeks 4 and 8; increased feed 
 23
efficiency in weeks 8 to 12; and prevented a decrease in plasma glucose 
concentrations and amylase activity.  The inconsistent increase in egg production 
and mass does not point to a true protective effect of GMA, which similarly can 
be argued to be correlated with the increase in feed efficiency during weeks 8 to 
12.   
Superactivated charcoal was not beneficial in protecting growing broilers 
against T-2 toxicosis (Edrington et al., 1997).  Growing broilers were fed a diet 
contaminated with 6 mg/kg BW T-2 toxin and supplemented with superactivated 
charcoal for 21 days.  Birds challenged with T-2 toxin, despite superactivated 
charcoal supplementation, exhibited reduced body weight gain, oral lesions, 
reduced feed intake, and changes in hematological parameters.   
As previously discussed, T-2 toxin induces PGE2 (prostaglandin E2 )and 
fever (Shohami and Feuerstein, 1986).   Shohami and coworkers (1987) 
attempted to remedy T-2 toxemia with dexamethasone, a cyclooxygenase 
inhibitor which interrupts arachadonic acid metabolism to PGE2.  Rats were 
intravenously dosed with a single 0.55 to 0.75 mg/kg BW T-2 toxin and then 
given dexamethasone (2 to 10 mg/kg BW) at 1, 24, and 48 hours post T-2 toxin 
challenge.  Survival was monitored for 1 week following the initial T-2 toxin dose.  
All rats given T-2 toxin alone died within 21 hours of the challenge.  However, 
only 44% mortality was observed in rats treated with dexamethasone at 1, 24, 
and 48 hours post T-2 toxin challenge.  Dexamethasone depressed PGE2 levels 
6 hours post T-2 toxin challenge, and enhanced survival rates of rats given a 
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lethal dose T-2 toxin as defined in this study.  Similarly, Tremel and coworkers 
(1985) showed reduced mortality among rats pretreated with 1.6 mg/kg BW 
dexamethasone and challenged 30 minutes later with 0.75 mg/kg BW T-2 toxin.  
Mortality was reduced 40% with dexamethasone pretreatment.  Dexamethasone 
reduced diarrhea and pulmonary edema, but increased gastrointestinal 
hemorrhages.  
Probiotics and Mycotoxins 
 Probiotics have been shown to protect subjects from the toxic effects of 
some mycotoxins, and thus have generated interest as a natural product useful 
against mycotoxicosis.  For six weeks, broilers were fed a diet supplemented with 
Eubacterium which is a microbial feed supplement from the bacterial strain BBSH 
797.   Intestinal tissues of the broilers were protected against 10 mg/kg diet 
deoxynivalenol as measured by duodenum and jejunum morphology (Awad et 
al., 2006).  BBSH 797 has been shown to partially hydrolyze T-2 toxin into HT-2 
toxin, a less toxic metabolite of T-2 toxin.  Additionally, T-2 tetraol, and 
scirpentriol were transformed into their respective, less toxic deepoxy forms 
(Fuchs et al., 2002).  In vitro studies have shown that a commercially available 
probiotic supplement, BioprofitTM, can bind to Aflatoxin B1. In an ex vivo 
experiment using avian duodenal tissue, Aflatoxin B1 absorption was slowed but, 
not inhibited, by BioprofitTM (Gratz et al., 2005).  Agawane and Lonkar (2004) 
were able to exhibit a protective effect of a probiotic containing yeast, 
Saccharomyces boulardii, on broilers hematobiochemical profile when 
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challenged with 0.5 ppm Ochratoxin A (Agawane and Lonkar, 2004).  
Supplementation with 10 mg/kg diet Saccharomyces boulardii against 0.5 ppm 
ochratoxin A alleviated the decreased values for total proteins, albumin, and 
globulin while preventing increases in serum creatinine and serum glutamate 
pyruvate transaminase seen in ochratoxin A-only-treated birds.   
Increasing T-2 toxin Toxicity 
 T-2 toxin toxicity may become a larger threat due to pesticide use and the 
recycling of poultry litter.  The use of organophosphates as pesticides in crop 
production may increase the problems associated with T-2 toxin; as they act 
through the production of esterase inhibitors which block the normal metabolism 
of T-2 toxin and promote hydroxylation instead of hydrolysis of the molecule (Wei 
and Chu, 1985).  In mice, the LD50 for the hydroxylated form of T-2 toxin, 3- 
hydroxyl T-2 toxin, at 4.63 mg/kg BW, is slightly higher than the LD50 of T-2 toxin, 
5.31 mg/kg BW (Yoshizawa et al., 1982).  Rat liver homogenates were used to 
study the effects of diisopropylfluorophosphate, an esterase inhibiting 
organophosphate insecticide (Ohta et al., 1977).  Diisopropylfluorophosphate 
inhibited the deacetylation of T-2 toxin, thus preventing biotransformation of T-2 
toxin to its less toxic derivatives (Thompson and Wannemacher, 1986).  As 
stated previously, biotransformation of T-2 toxin occurs through hydrolysis to less 
toxic derivatives.  It follows that T-2 toxin breaks down to the less toxic derivative 
HT-2 toxin which breaks down to the less toxic derivative T-2 tetraol (Yoshizawa 
et al., 1980a; Thompson and Wannemacher, 1986).  Therefore, use of 
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insecticides on crops contaminated with T-2 toxin could increase its toxicity by 
prevention of the biotransformation into these less toxic derivatives. 
 Eighty percent of a single dose T-2 toxin will appear in the excreta within 
48 hours post challenge, while residues can remain in the tissues for many days 
(Chi et al., 1978b; Yoshizawa et al., 1980b).  Exposure levels of T-2 toxin or 
other mycotoxins may be influenced by management practices.  Kuney and 
Sangani (2000) reviewed management practices for chickens and determined 
that manure removal occurred as often as every 2-3 days to every 2 weeks in 
houses with concert floors.  However, in houses with dirt floors, manure was 
removed only 2-3 times per year (Kuney and Sangani, 2000).  T-2 toxin 
contamination of manure may accumulate in houses and would be affected by 
the frequency of manure removal, and thus increase the exposure risk to resident 
birds.  Additionally, litter from chicken houses is often used for crop, grass, and 
vegetable production (Acosta-Martínez and Harmel, 2006).  As a consequence, 
T-2 toxin may aerosolize and present exposure issues to humans through 
inhalation.   
Aside from pesticide use, and recycled poultry litter, temperature has been 
shown to affect the toxicity of T-2 toxin.  T-2 toxin was found to inhibit the growth 
rate of Kluyveromyces marxianus and Saccharomyces cerevisiae at a control 
temperature of 30ºC (Gu et al., 1991).  Raising the temperature to 40ºC caused a 
further reduction in the yeasts’ growth rate which was attributed to T-2 toxin.  The 
combination of increased temperature and T-2 toxin caused greater detrimental 
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effects to the yeast.   Joffe (1983) reported that the 1943-1944 winters in 
Orenburg, Russia were warmer than average.  This increased temperature 
coupled with frequent spring freeze thaw cycles contributed to growth of 
Fusarium mycotoxins, and led to a large outbreak of Alimentary Toxic Aleukia 
(Joffe, 1983).  Thus, it is tempting to speculate that global warming could 
contribute to the toxicity of mycotoxins.  Over the past century, the Earth’s 
surface temperature has increased by 0.8°C; 75% of this increase has occurred 
over the last 30 years (Hansen et al., 2006).  T-2 toxin and other mycotoxins may 
pose a greater threat with the promise of a warmer future if coupled with optimal 
humidity. 
Tri101 
In 1998, Kimura and coworkers reported the isolation of trichothecene 
biosynthetic gene, tri101, found in Fusarium species.  Trichothecene 3-0-
acetyltransferase, produced by the tri101 gene was primarily responsible for 
converting isotrichodermol to isotrichodermin in the T-2 toxin biosynthetic 
pathway (Figure 1.2).  Disruption of the tri101 gene in Fusarium sporotrichioides 
resulted in accumulation of isotrichodermol, and subsequent inhibition of 
trichothecene biosynthesis (McCormick et al., 1999).  While tri101 has been 
proven to be required in T-2 toxin biosynthesis, it has also been shown to be 
involved in self defense against T-2 toxin (Kimura et al., 1998; McCormick et al., 
1999).  Transformed Schizosaccharomyces pombe cells containing the tri101
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Figure 1.2 Trichothecene biosynthesis (Kimura et al., 1998) 
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gene displayed resistance against 100 µg/ml T-2 toxin (Kimura et al., 1998).   To 
determine the protective mode of action, tri101 was cloned into an expression 
vector, transformed into Escherichia coli, and induced to obtain a crude enzyme 
fraction.  The crude enzyme fraction was incubated with trichothecenes and 
acetyl CoA, and the products were analyzed by TLC (Thin Layer 
Chromatography) and 1H NMR (Nuclear Magnetic Resonance).  It was confirmed 
that upon contact with trichothecenes and acetyl coA, the tri101 gene product 
acts as a method of self protection by inserting an acetyl group onto carbon-3 of 
3-hydroxy trichothecenes (Kimura et al., 1998; Figure 4).  An in vitro study using 
Newcastle disease virus-infected baby hamster kidney cells was conducted to 
measure the effect of trichothecenes on protein synthesis (Kimura et al., 1998).   
While it required five fold more 3-O Acetyl T-2 toxin to inhibit protein synthesis, 
15 ng/ml T-2 toxin inhibited protein synthesis.  Similarly, the 3-acetyl derivatives 
of deoxynivalenol, and diacetoxyscirpenol were one third less toxic than the 3-
hydroxy derivatives.  Additionally, protein synthesis was measured in a cell-free 
rabbit reticulocyte system.  The one-time inhibitory concentration to reduce 
protein synthesis by 50% (IC50) for T-2 toxin, DON, and DON fell between 0.3 
and 1.2 μg/ml while the IC50 concentrations of the 3-O-acetyl derivatives were 
greater than 100 times higher, indicative of reduced toxicity.  Tri101 has been 
shown to reduce the toxicity of T-2 toxin and other trichothecenes.   
The hypothesis of this research project is that tri101 gene product may 
protect avians against T-2 toxin.  To test this hypothesis, the objectives of the 
reported studies were: 
1.) To isolate and purify the tri101 gene product  
2.) To test the purified protein in an in vitro system for protective effects 
against T-2 toxin 
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Figure 1.3  Structural difference between T-2 toxin and 3-O-acetyl T-2 toxin 
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 Abstract  
Mycotoxins, toxic byproducts of fungi, represent an annual US agricultural 
loss of $500 million to $1.5 billion dollars.  Currently there are no feasible 
methods to effectively control this problem.  T-2 toxin, produced by Fusarium 
species, is among the most toxic of mycotoxins. The tri101 gene product, a self-
defense product of Fusarium graminearum, is involved in the biosynthesis of T-2 
toxin and converts T-2 toxin to a less toxic intermediate through acetylation at the 
3-carbon.  The purpose of this research project was to clone the tri101 gene into 
an expression vector, pQE30, and purify the gene product.  The tri101 gene was 
cloned into pQE30 and transformed into JM109 Escherichia coli competent cells.  
Sequence analysis confirmed proper ligation of tri101 into the expression vector.  
After induction, nitrilotriacetic acid agarose affinity chromatography was used to  
purify recombinant Tri101 (rTri101) protein. SDS-PAGE (Sodium Dodecyl Sulfate 
Polyacrylamide Gel Electrophoresis) analysis confirmed the presence of a single 
50 kDa protein as expected.  Purified rTri101 may be used to reduce harmful 
effects of T-2 toxin in vitro and in vivo to reduce economic losses due to 
trichothecene contamination of feedstuffs. 
Introduction 
Mycotoxins, secondary metabolites produced by fungi, are mostly 
produced by Aspergillus, Penicillium, and Fusarium genus (CAST, 2003).  T-2 
toxin is a trichothecene mycotoxin produced primarily by Fusarium and grows 
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optimally under cold, damp environmental conditions (Lesson, 1995; Joffe, 
1983).  In humans and animals, symptoms of T-2 toxicosis is characterized by 
oral lesions, hemorrhagic lesions of the skin and organs, feed refusal, decreased 
body weight gain, and death (Smalley, 1973; Mayer, 1953; Chi et al., 1977a; Chi 
et al., 1977b).  It is thought that T-2 toxin exerts its detrimental effects by 
inhibition of protein synthesis (McLaughlin et al., 1977).  In plants, T-2 toxin 
causes damage by inhibiting seed germination (Burmeister and Hesseltine, 
1970).  T-2 toxin had been identified as a biological warfare agent during the 
Cold War in southeast Asia (Rosen and Rosen, 1982).  Currently, there are no 
viable treatments to alleviate problems associated with T-2 toxin exposure. 
Fungal species that produce T-2 toxin have developed methods both to 
produce toxins and to protect themselves from the toxin (Cundliffe, 1989).   
Trichothecene biosynthesis, controlled by genes at 3 loci, include: the main 
trichothecene cluster including tri3 through tri14, tri101, and 2 regulatory genes 
including tri1 and tri16 (Brown et al., 2003).  Self protection lies within the tri101 
gene which has been reported in both Fusarium graminerium and Fusarium 
sporotrichioides (Kimura et al., 1998a; McCormick et al., 1999).  Tri101, involved 
in both the production and 3-acetylation of trichothecene mycotoxins, is 
responsible for the conversion of isotrichodermol to isotrichodermin, as well as, 
the synthesis and acetylation of T-2 toxin, deoxynivalenol, neosolaniol, and 4, 15 
diacetoxyscripenol (Figure 1.2; McCormick et al., 1999).  Self defense is 
achieved by conversion of the 3-hydroxy trichothecenes to 3-O-acetyl derivatives 
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(Kimura et al., 1998a).  Protective effects of tri101, tested in vitro by Kimura and 
coworkers (1998a), showed that the rTri101 combined with an acetyl source 
(acetyl CoA) and the 3-hydroxy form of T-2 toxin, deoxynivalenol, and 4, 15-
diacetoxyscripenol.   Acetylation of T-2 toxin, deoxynivalenol, and 4, 15-
diacetoxyscripenol was confirmed by thin layer chromatography.  Acetyl 
derivatives, tested for inhibition of protein synthesis as measured by luciferase 
activity in rabbit reticulocytes required a concentration 100 times greater than 3-
O-hydroxy derivatives.   Kimura and coworkers (1998a) also tested the ability of 
the trichothecene derivatives to inhibit the growth of yeast, transformed with a 
tri101-containing plasmid.  Growth of the tri101-containing yeast was not 
inhibited by exposure to 3-O-acetyl T-2 toxin whereas exposure to 3-hydroxy T-2 
toxin inhibited growth (Kimura et al., 1998a; McCormick et al., 1999).   
The discovery of tri101 has lead to in vivo and field studies to reduce the 
toxicity of trichothecenes.  Tobacco seed germination is inhibited by 4, 15-
diacetoxyscirpenol.  In an attempt to alleviate this problem, tri101-expressing 
transgenic tobacco plants were constructed.  Upon exposure to 4,15- 
diacetoxyscirpenol, tobacco plants expressing tri101 had a significantly higher 
rate of seed germination as compared to controls (Muhitch et al., 2000).  
Similarly, transgenic rice plants expressing tri101 were created by Ohsato and 
coworkers (2007).  Root length, a parameter commonly reduced by 
trichothecenes, was measured in controls and tri101 transgenic plants.  Tri101-
expressing rice plants were resistant to 40 µg/ml deoxynivalenol as measured by 
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root length.  In an attempt to measure a change in toxicity, Manoharan and 
coworkers (2006) created transgenic barley plants expressing tri101 and 
evaluated accumulation of deoxynivalenol in greenhouse trials.   Tri101-
transformed barley plants grown in a greenhouse were able to reduce the 
accumulation of deoxynivalenol, however in field trials, there was no decrease in 
deoxynivalenol accumulation in wild verses tri101 expressing transgenic plants 
(Manoharan et al., 2006).   
To date, no data is available concerning the application of the tri101 gene 
product in any animal species.  The hypothesis of this study was tri101 gene 
product may protect animals against the toxic effects of T-2 toxin in vitro.  To test 
this hypothesis, the objectives of this study were to: 
1.) Clone tri101 gene into expression vector pQE30 
2.) Express and purify recombinant Tri101 for in vitro and in vivo studies 
Materials and Methods  
PCR amplification of tri101 from pUCSVtri101  
Plasmid pUCSVtri101 was obtained as a gift from Kimura and coworkers 
(1998a).  The dried plasmid was reconstituted using 15 μL of distilled, deionized 
H20 (ddH20; this sample hereafter called reconstituted pUCSVtri101) and 
transformed into JM109 E. coli competent cells (Promega L2001, Madison, WI) 
following manufactor’s instructions (Appendix A).   Cells were plated on Luria 
Bertani (Matossian) agar plates (Fisher, BP 1426-500, Atlanta, GA) containing 
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ampicillin at a final concentration of 100 µg/ml (Sigma 0166-5G, St. Louis, MO) 
and incubated overnight at 37ºC (Appendix A).  To confirm the presence of the 
pUCSVtri101 in ampicillin-resistant colonies, DNA was extracted from 
representative colonies that were grown overnight at 37ºC in LB media plus 100 
µg/ml ampillicin using a QIAprep Spin Miniprep Kit (QIAGEN 27106, Valencia, 
CA; (Appendix B).  Agarose gel electrophoresis was performed to confirm 
isolation of plasmid DNA of the correct size (Appendix C).  To prepare a whole 
cell sample (JM109 cells containing pUCSVtri101) for pending Polymerase Chain 
Reaction (PCR), 2 colonies that were grown overnight at 37ºC in LB media plus 
100 µg/ml ampillicin were scraped and placed into 100 μL of distilled, deionized 
H20 and boiled for 10 minutes (hereafter called the whole cell sample).   
To amplify the tri101 gene, isolated plasmid DNA from pUCSVtri101 was 
used as a template in a PCR.  The nucleotide sequence as published in 
Genbank (accession number AB000874) has a coding sequence of tri101 with 
1356 base pairs from codon 135 to 1490.  Unique restriction enzymes Bam HI 
(Promega, R602A, Madison, WI) and Hind III (Promega R604A, Madison, WI) 
were chosen using the NEBCutter website 
(http://tools.neb.com/NEBcutter2/index.php; Vincze et al., 2003)  and added to 
the primers to allow proper orientation during ligation into the expression vector, 
pQE30 (QIAGEN 32915, Valencia, CA).  Bam HI was incorporated into the 5’-
end of the forward primer, and Hind III into the 5’-end of the reverse primer for 
PCR amplification.  Primer design was based on results from the Primer 3 web 
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tool (http://frodo.wi.mit.edu/; Rozen and Skaletsky, 2000).  Forward primer 
sequence was 5’ AAA GGA TCC ATG GCT TTC AAG ATA CAG CTC GAC 3’ 
and reverse primer was sequence 5’ CCC AAG CTT CTA ACC AAC GTA CTG 
CGC ATA CTT 3’ (restriction sites are underlined; Integrated DNA Technologies, 
Skokie, IL).  The tri101 gene was PCR amplified from both whole cell sample and 
from reconstituted plasmid pUCSVtri101 using above primers (Appendix D).   
Following the PCR reaction, DNA from both samples was purified using 
QIAquick PCR Purification Kit Protocol (QIAGEN 28104, Valencia, CA; Appendix 
E).   Each purified product was digested with restriction enzymes BamHI and 
HindIII (Appendix F).  Following digestion, tri101 DNA was purified (Appendix E) 
and DNA band size from the 2 samples were compared by agarose gel 
electrophoresis (Appendix C).   
Ligation of tri101 into expression vector pQE30 
Tri101 prepared from the amplified whole cell sample was ligated into the 
pQE30 vector (QIAGEN 32915, Valencia, CA; Appendix G1).  The resulting 
plasmid, pQEtri101, was transformed into JM109 competent cells (Appendix G2).  
Twelve transformed colonies were randomly selected from ampillicin resistant 
plates and inoculated into 5 mL aliquots of LB broth supplemented with ampicillin 
(100 µg/ml final concentration), and grown at 37ºC overnight.   Plasmid DNA 
from pQEtri101 was extracted using a QIASpin MiniPrep Kit (Appendix B).  
Agarose gel electrophoresis was used to confirm DNA from colonies (suspected 
to contain plasmid pQEtri101) were larger in size than expression vector, pQE30 
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(Appendix C).   Sequence analysis was completed at the University of 
Tennessee, Knoxville Molecular Biology Resources Facility, and confirmed that 
the PCR product had ligated correctly into pQE30 and contained no frameshifts. 
Amplification of tri101 from pQEtri101  
To confirm that pQEtri101 plasmid transformants contained the tri101 
gene of correct size, another PCR amplification was completed.  Four test 
samples were amplified (Appendix H).  Agarose gel electrophoresis confirmed 
successful amplification of tri101.  To determine if restriction enzymes Bam HI 
and Hind III had been correctly incorporated into tri101 by PCR, DNA was 
digested (Appendix I) and gel electrophoresis confirmed DNA of correct size.  
Expression and Purification of rTri101 
Expression 
 Construct JM109/pQEtri101 cells were grown in 5mL LB media plus 
ampicillin (100 µg/ml final concentration; Sigma 0166-5G, St. Louis, MO) and 
incubated overnight at 37°C.  The following morning, the 5 ml culture was added 
into 50mL of 37ºC LB media supplemented with ampicillin (final concentration of 
100 µg/ml) and were allowed to grow to an optical density (OD) at 600 nm value 
was between 0.5 and 0.7 nm.  At this point, a 1 ml sample was taken for sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE; “pre-induction” 
sample).  The remaining cell culture was induced with 2 mM (final concentration) 
Isopropyl-β-D-Thiogalactoside (IPTG).  One mL samples were taken every hour 
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for 4 hours following addition of IPTG (SDS-PAGE “post- induction” samples).  
SDS PAGE (Appendix J) was performed to examine expression of rTri101.   
 To experimentally check the location of rTri101, it was expressed using a 
2 hour induction with IPTG as previously described.  After induction, cells were 
harvested by centrifugation at 4ºC for 20 minutes at 3800 x g, washed and 
resuspended in 5 ml of 1x phosphate buffered saline (PBS; Sigma P5493, St 
Louis, MO).  Lysozyme (Sigma L3790, St Louis, MO) was added at 1 mg/ml and 
cells were lysed by sonication and centrifuged for 30 minutes at 4ºC at 15,000 x 
g.  SDS PAGE was performed to examine the location of rTri101 either in the 
soluble (supernant ) fraction or in the insoluble (pellet) fraction.   
To predict the theoretical cellular location of the rTri101 product following 
induction and sonication, Signal P (www.cbs.dtu.dk/services/SignalP/) and 
TMHMM (http://www.cbs.dtu.dk/services/TMHMM/) web tools were implemented 
(Bendtsen et al., 2004; Nielsen et al., 1997; Krogh et al., 2001; Sonnhammer et 
al., 1998).  The Signal P web tool analyzes properties of amino acids within a 
protein sequence to predict the presence or absence of signal peptides.  Signal 
peptides, comprised of 1 to 12 positively charged amino acids followed by region 
of 9 to 14 hydrophobic amino acids, are located near the N-terminal of secretory 
proteins (Perlman et al., 1983; von Heijne et al., 1983).  TMHMM web tools 
analyze the properties of amino acids within a translated protein sequence to 
predict the presence or absence of transmembrane regions indicative of cellular 
location (Sonnhamer et al., 1998).  Transmembrane regions, comprised of an 
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expanse of 20 or more hydrophobic amino acids in an α helix, anchor membrane 
bound proteins to the lipid bilayer (Nelson and Cox, 2005).  Thus proteins 
secreted from the cell will have signal peptides, while those which are anchored 
in the cell membrane will have a transmembrane region.  
Purification of rTri101 from inclusion bodies 
For purification of rTri101 from inclusion bodies (with Empigen BB), 
QIAGEN’s QIAExpressionist protocol was followed (Appendix K; QIAGEN, 2003).  
Elution fractions 2 and 3 of rTri101 purified from inclusion bodies (rTri101 IB) 
were combined and confirmed by SDS PAGE (Appendix J).  The protein was 
dialyzed using a Pierce Slide-A-Lyzer 0.5 to 3 mL Dialysis cassette (Pierce 
66370, Rockford, IL; Appendix L) according to protocol.  Empigen (final 
concentration 1%) was added at this step because rTri101 precipated during 
dialysis.  After solubilizing, rTri101 IB was sterilized by filtration through a 0.2μm 
syringe filter.  Relative concentration of 270 µg/ml rTri101 IB was determined by 
Pierce BCA protein assay (Pierce 23225, Rockford, IL; Appendix M).  Purified 
protein was aliquoted into 100 μL fractions and stored at -20ºC. 
Purification of rTri101 from soluble fractions 
Purification of rTri101 was completed using the soluble fraction (rTri101 
SF) following the QIAExpressionist protocol (Appendix N, QIAGEN 2003).  SDS 
PAGE (Appendix J) confirmed that rTri101 was located in the supernant after 
induction and sonication.  Eluted fractions 2 and 3 were combined.  The 
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concentration of 250 µg/ml rTri101 SF was determined by Pierce BCA protein 
assay (Appendix M) and stored at -20°C in 5 µL aliquots. 
Production of crude enzyme rTri101 
The protocol of Kimura and coworkers (1998) was used to produce a 
crude enzyme fraction of rTri101 (Appendix O) , and to replicate their 
experiments which showed protection of yeast cells against T-2 toxin.  Location 
of rTri101 in the supernant fraction after sonication and centrifugation was 
confirmed by SDS PAGE (Appendix J). .  Total protein concentration of 250 
µg/ml was determined with the Pierce BCA protein assay (Appendix M) and 
stored at -20°C in 5 µL aliquots. 
Results & Discussion 
Transformation of pUCSVtri101 and amplification of tri101 from 
pUCSVtri101 
Following transformation of pUCSVtri101 into JM109 cells, plasmid DNA 
from transformants showed a band at ~ 5Kb in lanes 2 and 3 which correlated 
with the correct size of pUCSVtri101 as published by Kimura and coworkers 
(1998a; Figure 2.1).  The 3 conformational forms of DNA, supercoiled, nicked 
circular and linear, migrate at different rates in agarose gel electrophoresis 
(Thorne, 1966; e 1967).  If agarose concentration is less than .92%, then 
supercoiled will migrat fastest followed by nicked circular, and lastly linear which 
migrates slowest (Grossman and Johnson, 1977).  The band near 3.5 Kb Figure  
 Figure 2.1  Agarose Gel Electrophoresis of plasmid DNA from JM109 cells 
transformed with pUCSVtri101.  Lane 1- standard marker.  Lanes 2 & 3- plasmid 
DNA from 2 representative colony transformants. 
  
in 2.1 lanes 2 and 3 was supercoiled form of DNA from plasmid pUCSVtri101 
and therefore, migrated further than expected. 
 Amplification of the tri101 gene from whole cell pUCSVtri101 transformed 
JM109 cells produced a band that migrated near the estimated size of tri101 of 
1.356 Kb (Figure 2.2, Lane 2)., and agrees reconsistuted pUCSVtri101 product 
Kimura and coworkers (1998a; Figure 2.2, Lane 3).   From these results, it was 
concluded that tri101 had been successfully amplified and transformed into 
JM109 cells. 
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 Figure 2.2  Agarose gel electrophoresis of PCR amplified tri101. Lane 1-standard 
marker.  Lane 2- PCR amplified DNA from whole cell transformed JM109 cells 
containing pUCSVtri101.  Lane 3- PCR amplified DNA from reconsistuted 
pUCSVtri101 (Kimura et al., 1998a). 
 
 
Ligation into pQE30 and Transformation of pQEtri101 into JM109cells 
Following successful amplification of tri101, the gene was ligated into the 
expression vector, pQE30 and retransformed into JM109 cells (Figure 2.3).  Gel 
electrophoresis of plasmid DNA from the pQE30 vector plus tri101 showed a 
band of less than 3 Kb which was less that the expected size of 4.756 of 
pQEtri101 (pQE30=3.4 Kb; tri101=1.356 Kb).  Similarly, the pQE30 plasmid DNA 
migrated to the size analogous with something less than its expected size (3.4 
Kb) of about 2 Kb.  It is common in agarose gel electrophoresis for plasmid DNA 
to migrate further than expected.  It was more important that 4 of the colonies 
were larger than the pQE30 expression vector control (Figure 2.3, lane  
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 Figure 2.3  Agarose gel electroporesis pQEtri101 transformed in JM109 cells. 
Lane 1- Standard marker; Lanes 2 through 12- Individual, isolated colonies;  
Lane 13-  Blank;  Lane 14- Individual, isolated colony; Lane 15  Control, 
expression vector pQE30. * Indicates successfully ligated plasmids.  ° Indicates 
pQE30 control vector 
 
15).   DNA sequence analysis of DNA from Lane 14 confirmed that tri101 had 
correctly ligated into pQEtri101 and contained no frame shifts (Figure 2.4). 
Amplification of tri101 from pQEtri101 
 Following DNA sequence analysis of DNA from Lane 14 (Figure 2.4), 
plasmid DNA of pQEtri101 from lanes 2, 5, 9, and 14 were further tested by PCR 
to verify successful ligation of a product of correct size (Figure 2.5).  Agarose gel 
electrophoresis showed that each of the pQEtri101 plasmids were correctly 
amplified as indicated by their size of 1.356 Kb.   
Test for tri101 orientation and activity of restriction enzymes  in pQEtri101 
 To confirm proper orientation of the tri101 gene in the pQE30 expression 
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ATAGAGGAGAATTAACTATGAGAGGATCGCATCACCATCACCATCACGGATCCATGGC
TTCAAGATAGGAAGAACACCCTCGGCCAGCTACCAGGCCTCCTTTCGATCTACACCCA
AATCAGTCTCCTCTACCCCGTCTCTGATCCCTCTCAATATCCCACTATTGTCAGCACCT
TCGAGCAAGGTCTTAAGCGCTTCTCCGAAGCCGTCCCATGGGTCGCAGGCCAGGTCA
AAGCCGAGGGCATTAGCGAGGGAAACACGGGAACTTCCTTTATCGTCCCTTTTGAGGA
CGTTCCTCGTGTTGTAGTGAAAGACCTCCGCGATGATCCTTCAGCGCCCACGATCGAG
GGTATGAGAAAGGCGGGATACCCTATGGCGATGTTTGACGAGAACATCATCGCGCCA
AGGAAGACGTTACCTATTGGACCTGGTACTGGCCCCGACGACCCAAAGCCTGTGATTC
TATTGCAGCTCAACTTCATCAAGGGCGGACTCATCCTCACTGTCAACGGACAGCACGG
TGCTATGGATATGGTAGGCCAAGATGCGGTGATCCGTCTACTCTCCAAGGCGTGCCGT
AACGACCCATTCACCGAAGAGGAAATGACGGCCATGAACCTCGATCGCAAGACGATA
GTTCCTTACCTTGAAAACTACACGATTGGCCCCGAGGTAGATCATCAGATTGTCAAACC
TGATGTAGCTGGTGGTGACGCTGTTCTCACGCCGGTCAGTGCAAGCTGGGCGTTCTT
CAATTCAGCCCCAAGGGCATGTCAGAGCTCAGGATGCTGCTACCAAGACTCTTGACGC
ATCAACAAAGTTCGGGTCGACTGACGATGCTCTTTCGGGTTCATCTGGAATCGGCTCT
CGCGTGGTCTCGAAAAAATCGATGGCTCTGCACCTACCGAGTTCTGCCGGCTGTGATG
CTCCACCGGAATGGGGTTTCGAAAAATACCAGGCCTTTTAAAAATGACCTACCAAAGA
CCATTGGGGAATGCCAAGAGTATGGGGAACGGTTCCGCTTTTAAAAATCGACCCGGGA
TGGCAAAAAAAAGGTTGGAGTCTTGCAAACCCAAAGTCAAGTTTTAGGGGGAGGGGAC
CTTTCCCGGTGTGTTTG 
 
 
Figure 2.4  DNA sequence analysis of tri101 with 6-Histidine tag (outlined with 
dashed box), Bam HI (underlined), and Hind III.   
 
vector, DNA was sequenced.  Sequence analysis proved correct orientation 
(Figure 2.4). To prove that the restriction enzymes were functional, DNA was 
digested using restriction enzymes Hind III and Bam HI.  In Figure 2.6, samples 
in lanes 2, 3, and 5 showed 2 bands 3.4 Kb and 1.4 Kb in size.  This was correct 
for the expression vector, pQE30 (3.4 Kb) and tri101 (1.4 Kb).  In lane 4, a single 
band, 5 Kb in size and indicated that only one of the restriction enzymes had 
correctly cut the plasmid or that the restriction enzyme sites were non-functional.  
Products from lanes 2, 3, and 5 were kept. 
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 Figure 2.5  Agarose Gel Electrophoresis of PCR DNA from pQEtri101 plasmids.  
Lane 1-  standard marker.  Lanes 2 through 6-  PCR products that had indicated 
successful ligation of tri101 into pQEtri101 
 
 
Figure 2.6  Agarose gel electrophoresis of digested pQEtri101.  Lane 1 contains 
the standard marker.  Lanes 2, 3, 4, and 5 contains Hind III and Bam HI digested 
plasmids corresponding to lanes 2, 5, 9, and 14 respectively from Figure 2.3.  
Note the transformant in lane 4 did not cut successfully. 
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Expression and Purification of tri101 
Expression  
 Once it was established that the tri101 gene was of correct size and 
sequence, experiments were begun to express the gene.  Samples were 
collected at 0, 1, 2, 3, and 4 hours post induction with IPTG.  The expected size 
of rTri101 was 49,600 kilodaltons (kDa; Kimura et al, 1998a).  A protein band of 
the correct size was observed in the 2, 3, and 4 hour post induction samples 
(Figure 2.7 
 
 
Figure 2.7  SDS PAGE results for rTri101 expression in construct 
JM109/pQEtri101.  Lane 1- standard marker.  Lane 2 - pre-IPTG-induced 
sample.  Lanes 3, 4, 5, and 6- post-IPTG-induction at 1, 2, 3, and 4 hours post 
induction, respectively.  Note that maximal induction occurred at greater than 2 
hours. 
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Purification of rTri101 from inclusion bodies 
 Induction of the rTri101 in construct JM109/pQEtri101 caused a large 
production of protein which was found in the insoluble or pelleted fraction (Figure 
2.8).  The location of rTri101 in the insoluble fraction was unexpected as Kimura 
and coworkers (1998a; 1998b; 2003) and Garvey and coworkers (2007) found 
rTri101 in the supernant or soluble fraction.  Furthermore, Signal P sequence 
analysis did not reveal the presence of a signal peptide (Bendtsen, et al., 2004).  
Additionally, the sequence of rTri101 did not contain any largely hydrophobic or 
transmembrane regions as determined by TMHMM software  (Krogh et al., 
2001;Sonnhamer et al., 1998).  Sequence analysis showed rTri101 was cytosolic 
and soluble despite its location within the pellet in this study.  The fact that 
rTri101 was found in the pellet is explained by inclusion bodies (formed by 
overexpression of the gene and thus made heavy enough to pellet during 
centrifugation).  Marston (1986) reported the formation of insoluble aggregates of 
protein, called inclusion bodies of during the production of recombinant proteins 
in E. coli.  To solubilize the rTri101 protein induced by IPTG, a mild detergent 
was used.  Empigen BB, a mild zwitterionic detergent, was used to break the 
inclusion bodies (Lowthert et al., 1995) and was successful as SDS PAGE 
showed proteins of the expected size following treatment with Empigen (Figure 
2.9).  BCA protein assay results indicated that the total protein concentration in 
the eluted fractions of rTri101 IB was 270 µg/mL (Table 2.1). 
 Figure 2.8  SDS PAGE gel analysis of induction, location, and wash fractions 
produced during purification of rTri101 IB.  Lane 1- standard marker;  Lane 2- 
pre-IPTG-induced sample;  Lane 3-  post-IPTG-induced sample; Lane 4- total 
proteins found within the supernant (soluble) fraction following sonication and 
centrifugation;  Lane 5- total proteins found within the pellet (insoluble) fraction 
following sonication and centrifugation.  Lanes 7 through 10- total proteins found 
in wash fractions 1 through 4 from the Ni-NTA column (devoid of rTri101).   
 
 
Figure 2.9  SDS PAGE of eluted rTri101 produced during purification of rTri101 
IB.  Lane 1- standard marker;  Lanes 2 through 6- total proteins contained within 
the eluted fractions of rTri101 from the column. 
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 Table 2. 1 Table 2.1 Total Protein Concentrations of rTri101 under differing 
purification schemes 
Purification method Concentration (µg/ml) 
rTri101 purified from inclusion bodies 250 μg/ml 
rTri101 purified from soluble fractions 270 μg/ml 
Crude enzyme fraction rTri101 2044 μg/ml 
 
Purification of rTri101 from soluble fractions 
Recombinant Tri101 was purified from soluble fractions (rTri101 SF) which 
required induction with a lower concentration of IPTG (1 mM) for a shorter period 
of time (2 hour induction period) to both decrease the amount of protein 
expressed and to avoid formation of large quantities of inclusion bodies.  The 
majority of rTri101 was found in supernant fraction which was similar to results 
reported by Kimura and coworkers (1998a, 1998b, 2003) and Garvey and 
coworkers (2007; Figure 2.10).  SDS PAGE showed successful purification of 
rTri101 SF (Figure 2.11).  The BCA protein assay results indicated that the total 
protein concentration in the eluted fractions of rTri101 SF was 250 µg/mL (Table 
2.1).   
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 Figure 2.10  SDS PAGE analysis of induction, location, and wash fractions 
produced during purification of rTri101 SF.  Lane 1-  standard marker.  Lane 2- 
total proteins from the pre-IPTG induced cells.  Lane 3- total proteins from the 
post 1mM IPTG induced cells.  Lane 4- total proteins found within the pellet 
fraction (containing rTri101) after sonication and centrifugation.  Lane 5- total 
proteins found within the supernant fraction  after sonication and centrifugation.  
Lane 6 contains the standard marker.  Lane 7, 8, 9, 10, 11, & 12 contain total 
proteins from wash fractions of the column devoid of rTri101 
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Figure 2.11  SDS PAGE of eluted rTri101 SF produced during purification. Lane 
1- standard marker.  Lane 2- total proteins from the pre-IPTG induced cells.  
Lane 3- total proteins from the post 1mM IPTG induced cells.   Lane 4- total 
proteins from the flow through of the column, which is devoid of rTri101.  Lanes 
5, 6, 7, 8, 9, & 10- total proteins (including rTri101) from eluted fractions 1-7 
respectively 
Production of a Crude Enzyme Protein 
  A crude enzyme fraction of rTri101 was produced in order to confirm the 
work of Kimura and coworkers (1998a), who were able to show protective effects 
of rTri101 against T-2 toxin in an in vitro system using yeast cells.  For the 
production of a crude enzyme fraction, JM109 cells containing pQETri101 was 
induced for 2 hours with 1 mM IPTG.  SDS PAGE results indicated the protein 
was effectively induced, and located within the supernant (Figure 2.12).  The 
location of rTri101 in the supernant (soluble) agreed with results previously 
reported Kimura and coworkers (1998a; 1998b; 2003) and Garvey and 
coworkers  (2007).  The total protein concentration of the crude enzyme protein 
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Figure 2.12  SDS PAGE of the crude enzyme fraction of rTri101.  Lane 1- 
standard marker.  Lane 2- total proteins from the pre-IPTG induced cells.  Lane 3 
total proteins from 2 hours post IPTG induction of cells.   Lane 4- total proteins 
found within the supernant after sonication and centrifugation, and is devoid of 
rTri101  Lane 5- total proteins found within the pellet fraction after sonication and 
centrifugation, and contains rTri101. 
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was 2 mg/ml.  As expected, this is much higher than either rTri101 IB or SF 
isolates because the crude enzyme fraction contained other cellular proteins 
(Table 2.1).   
Conclusion 
Agarose gel electrophoresis confirmed the amplification and ligation of the 
tri101 into expression vector pQE30.  Successful expression and purification of 
rTri101 was achieved from inclusion bodies, soluble fractions and crude 
extraction methods.  Although the location of rTri101 IB was not as expected; 
SDS PAGE analysis of rTri101SF and crude rTri101 showed it to be in the 
soluble fraction and agrees with results by Kimura and coworkers (1998a; 1998b; 
2003) and Garvey and coworkers (2007).   The following in vitro experiments use 
each form of rTri101. 
 
. 
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3. IN VITRO STUDIES TO DETERMINE BIOLOGICAL 
ACTIVITY OF RECOMBINANT TRI101 SUPPLEMENTED 
WITH ACETYL COA ON HD11 CELLS CHALLENGED 
WITH T-2 TOXIN 
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Abstract 
Experiments were conducted to test the protective effects of 3-O-
acetyltransferase, the gene product of tri101, against challenge with T-2 toxin in 
vitro.  Three-O-acetyltransferase was expressed and purified from inclusion 
bodies (rTri101 IB), soluble fractions (rTri101 SF), and in a crude enzyme fraction 
(crude rTri101).  HD11 chicken macrophage cells were incubated with each 
isolate of rTri101 and challenged with T-2 toxin.  Number of live cells per 
treatment were expressed as a percent of controls, set to 100%.  Greatest 
protective effects of rTri101 were observed from isolates purified from soluble 
fractions.  At 1nM rTri101 SF, complete protection was observed against 0.1 ppm 
(0.2 µM) T-2 toxin (99% rTri101 SF and T-2 toxin verses 54% T-2 toxin alone; 
p<0.05).  At 2 nM rTri101 SF, partial protection was observed against 0.5 ppm (1 
µM) T-2 toxin (83% rTri101 SF and T-2 toxin verses 46% T-2 toxin alone; 
p<0.05).  Protective effects of rTri101 SF were limited with higher amounts of T-2 
toxin, suggesting a threshold for protection.  Further studies will be conducted to 
test for protective effects of rTri101 SF in vivo. 
Introduction 
T-2 toxin, a trichothecene mycotoxin grows optimally in cold, wet climates 
(Joffe, 1983).  During WWII, the population of an entire region of Russia was 
nearly destroyed due to Alimentary Toxic Aleukia, a disease caused by T-2 toxin 
contamination of grain (Mayer, 1953). A more recent study reported undisclosed 
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amounts of T-2 toxin were found in 20% of 3490 wheat, barley, oat, rye, and corn 
samples from the European Union (Schothorst and Egmond, 2004). Similar to 
humans, health problems occurred when contaminated grains were fed to 
livestock.  In particular, poultry exhibited sensitivity to T-2 toxin, and resulted in 
physical signs such as oral lesions, neural abnormalities, altered feathering, 
decreased weight gain, feed refusal, decreased egg production, and lethargy 
(CAST, 2003, Wyatt et al., 1972; Wyatt et al., 1973a; Wyatt et al., 1973b; Wyatt 
et al., 1975a; Wyatt et al., 1975b; Chi et al., 1977a; Chi et al., 1977b: Chi et al., 
1977c).  T-2 toxin caused immunosuppression rendering birds more susceptible 
to disease (Corrier, 1991).  Poultry who show physical signs of sickness such as 
oral lesions cannot be slaughtered as described by the Poultry Products 
Inspection Act (FSIS, 2004), and thus increase monetary losses to producers.   
 Thompson and Wannemacher (1986) observed that addition of an acetyl 
group at C3 of T-2 toxin resulted in a 5 to 100 fold reduction in toxicity.  Kimura 
and coworkers (1998a) reported tri101 (trichothecene 3-0-acetyltransferase), 
found in Fusarium graminearum, was involved in self protection.  Tri101 
functioned by adding an acetyl group to the C3 position on T-2 toxin, forming 3-
O-acetyl T-2 toxin.  Since then, tri101 has been successfully inserted into 
transgenic rice, tobacco, and barley plants (Muhitch et al., 2000; Manoharan et 
al., 2006; Ohsato et al., 2007).  In each of these studies, tri101 was able to 
confer resistance to the plant against trichothecene challenge in laboratory 
studies.  However, this resistance has yet to be shown in field studies.     
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 The objective of this study was to investigate the ability of  the purified 
gene product of tri101 in an in vitro system for protective effects against T-2 
toxin.  As discussed in chapter 2, rTri101 was purified under native and 
denaturing conditions.  A third semi purified crude enzyme fraction was also 
produced.  Each method of purification was examined to determine optimal 
conditions to maintain biological activity of rTri101.  Experiments were conducted 
with HD11 chicken macrophage cells to: 
1.  Determine the dose of T-2 toxin which caused 50% death of HD11 
cells. 
2. Test acetyl CoA 
A. Determine if acetyl CoA was toxic  
B. Determine if acetyl CoA conferred protection against T-2 toxin in 
vitro 
3. Test rTri101 purified from inclusion bodies (rTri101 IB) 
A.  Determine if rTri101 (IB) was toxic to HD11 cells. 
B. Determine if rTri101 IB conferred protection against T-2 toxin in 
vitro when supplemented with acetyl CoA. 
4. Test rTri101 SF 
A. Determine if rTri101 SF was toxic to HD11 cells.   
B. Determine if rTri101 SF conferred protection against T-2 toxin in 
vitro when supplemented with acetyl CoA. 
5. Test Crude enzyme fraction (CEP) of rTri101  
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A. Determine if CEP rTri101 was toxic to HD11 cells. 
B. Determine if crude enzyme fraction of rTri101 conferred 
protection against T-2 toxin in vitro when supplemented with 
acetyl CoA. 
Materials and Methods 
Maintenance of the HD11 cell line 
HD11 chicken macrophage cells (Beug et al., 1979) were maintained in RPMI 
1640 media (Sigma R4130, St Louis, MO) supplemented with 5% fetal bovine 
serum (FBS; Invitrogen 26170-043, Carlsbad, CA) and 1% antibiotics (Sigma 
P4083, St Louis, MO; final concentration 50units/ml penicillin, 0.05mg/ml 
streptomycin, and 0.1mg/ml neomycin; hereafter called complete media).  Cells 
were grown to confluency in a Baxter Ultra Tech incubator at 39ºC with 95% air 
and 5% CO2 using Corning 25cm2 tissue culture flasks (Fisher 1012630, Atlanta, 
GA). At confluency, cells were manually scraped using a cell scraper (Fisher 
087732, Atlanta GA) and transferred to new flasks.   
In vitro protocol 
For each of the 5 experiments, the following protocol was followed.  Cells 
near confluency were scraped, pelleted by centrifugation at 50 x g for 2 minutes, 
and resuspended in 2 ml of complete media.  Cell concentration was calculated 
by trypan blue exclusion (Sigma T6146, St Louis, MO) using a 10:1 dilution of 
cell suspension to trypan blue.  One hundred and fifty thousand cells were plated 
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per well into Falcon 48 well plates (0.75 cm2;  Beckman Dickinson 3078, Lincoln 
Park, NJ) using 750 µL complete media.  HD11 cells were allowed to attach for 
24 hours, after which, media was removed and replaced with treatments as 
described below.  In all experiments, cells were incubated with treatments for 18 
hours.  Following the 18 hour incubation, cells were manually scraped from each 
individual well using a 1000 µl pipette tip, pelleted by centrifugation at 14,000 rpm 
(16,000 x g) for 18 seconds in a Eppendorf Microcentrifuge 5415C (Fisher 05-
406-2  Atlanta, GA), resuspended in 500 μL warmed (37ºC) phosphate buffered 
saline (PBS; Invitrogen 21600, Carlsbad, CA), repelleted by centrifugation at 
14,000 rpm (16,000 x g) for 18 seconds in a Eppendorf Centrifuge 5415C (Fisher 
05-406-2  Atlanta, GA), and resuspended in either 100 or 125 μL of PBS.  Cells 
were immediately counted using trypan blue exclusion at 200x magnification 
using a bright field Nikon Eclipse E800 microscope (Marietta, GA).  Each 
experiment consisted of 3 plates containing 3 replicates of each treatment per 
plate (except Experiments 3A and 5A which only consisted of 1 plate containing 
2 replicates of each). 
Experiment 1.  Determine the dose of T-2 toxin which caused 50% death of 
HD11 cells 
A.    HD11 cells were plated at a density of 150,000 cells per well 
and challenged with: 
1.  0 pppm T-2 toxin (Sigma 4887, St Louis, MO) in complete  
media 
2.  0.1 pppm T-2 toxin in complete media 
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3.  0.5 pppm T-2 toxin in complete media 
4.  1 pppm T-2 toxin in complete media 
Experiment 2- Test acetyl CoA 
A.   Determine if acetyl CoA was toxic to HD11 cells 
HD11 cells were plated at a density of 150,000 cells per well 
and treated with: 
1.  0 μM acetyl CoA (Sigma P2056, St Louis, MO) in 
complete media 
2.  5 μM acetyl CoA in complete media 
3. 10 μM acetyl CoA in complete media 
4.  25 μM acetyl CoA in complete media   
 
B.    Determine if acetyl CoA conferred any protective effects 
against T-2 toxin in vitro.  Four experiments were conducted 
to test increasing doses of acetyl CoA for the protective 
effects against T-2 toxin.  HD11 cells were plated at a 
density of 150,000 cells per well and treated with: 
Test I- 5µM acetyl CoA verses 0.1 ppm T-2 toxin 
 
1.  Complete media 
2.  5 µM acetyl CoA in complete media 
3.  5 µM acetyl CoA and 0.1 ppm (0.2 µM) T-2 toxin in   
    complete media 
4.  0.1 ppm (0.2 µM) T-2 toxin in complete media 
 
Test II 10 µM acetyl CoA verses 0.5 ppm (1 µM) T-2 toxin 
 
1. Complete media 
2. 10 µM acetyl CoA in complete media 
3. 10 µM acetyl CoA and 0.5 ppm (1 µM) T-2 toxin in      
     complete media  
4. 0.5 ppm (1 µM) T-2 toxin in complete media 
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Test III 25 µM acetyl CoA verses 1 ppm (2 µM) T-2 toxin 
 
1. Complete media 
2. 25 µM acetyl CoA in complete media 
3. 25 µM acetyl CoA and 1 ppm (2 µM) T-2 toxin in    
       complete media 
4. 1 ppm (2 µM) T-2 toxin in complete media 
 
Experiment 3- Test rTri101 IB 
A.    Determine if rTri101 IB was toxic to HD11 cells.  
HD11 cells were plated at 150,000 cells per well and 
challenged with: 
1.  Complete media 
2.  1 nM rTri101 IB in complete media 
3.  10 nM rTri101 IB in complete media 
4.  100 nM rTri101 IB in complete media 
 
B.     Determine if rTri101 IB supplemented with acetyl CoA 
conferred any protective effects against T-2 toxin in vitro.  
Results from experiment 3A showed that 1nM rTri101 IB was 
not toxic.  HD11 cells were plated at a density of 150,000 
cells per well and challenged with: 
1.  Complete media  
2.  1 nM rTri101 IB plus 5μM acetyl CoA in complete media 
3.  1 nM rTri101 IB, 5μM acetyl CoA, and 0.1 ppm (0.2 µM)     
     T-2 toxin in complete media 
4.  0.1 ppm (0.2 µM) T-2 toxin in complete media 
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Experiment 4- Test rTri101 SF 
A.     Determine if rTri101 SF was toxic to HD11 cells 
HD11 cells were plated at 150,000 cells per well and 
challenged with: 
1.  Complete media 
2.  1 nM rTri101 SF and 5 µM acetyl CoA, in complete media 
3.  2 nM rTri101 SF and 10 µM acetyl CoA in complete    
     media 
4.  5 nM rTri101 SF and 25 µM acetyl CoA in complete     
     media 
 
B.    Determine if rTri101 SF conferred protection against T-2 
toxin in vitro when supplemented with acetyl CoA 
Test I. 1 nM rTri101 SF and 5 µM acetyl CoA verses 0.1 
ppm (0.2 µM) T-2 toxin 
1.  Complete media  
2.  1 nM rTri101 SF plus 5μM acetyl CoA in complete media 
3.  1 nM rTri101 SF, 5μM acetyl CoA, and 0.1 ppm (0.2 µM) 
T-2 toxin in complete media 
4.  0.1 ppm (0.2 µM) T-2 toxin in complete media 
 
Upon finding protective effects of rTri101 SF, higher levels of 
rTri101 SF, acetyl CoA, and T-2 toxin were examined. 
Test II.  2 nM rTri101 SF and 10 µM acetyl CoA verses 0.5 
ppm (1µM) T-2 toxin 
1.  Complete media  
2.  2 nM rTri101 SF plus 10 μM acetyl CoA in complete 
media 
3.  2 nM rTri101 SF, 10 μM acetyl CoA and 0.5 ppm (1 µM) 
T-2 toxin in complete media 
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4.  0.5 ppm (1 µM) T-2 toxin in complete media 
 
Test III. 1 nM rTri101 SF and 5 µM acetyl CoA verses 1 ppm 
(2 µM) T-2 toxin 
1.  Complete media  
2.  1 nM rTri101 SF plus 5μM acetyl CoA in  
complete media 
3.  1 nM rTri101 SF, 5μM acetyl CoA, and 1 ppm (2 µM) T-2 
toxin in complete media 
4.  1 ppm (2 µM) T-2 toxin in complete media 
 
Test IV.  5 nM rTri101 SF and 25 µM acetyl CoA verses 1 
ppm (2 µM) T-2 toxin 
1.  Complete media 
2.  5 nM rTri101 SF plus 25 μM acetyl CoA in complete 
media 
3.  5 nM rTri101 SF, 25 μM acetyl CoA, and 1 ppm (2 µM) T-
2 toxin in complete media 
4.  1 ppm (2 µM) T-2 toxin in complete media 
 
Experiment 5- Test crude rTri101 
A.  Determine if crude enzyme fraction of rTri101 was toxic to 
HD11 cells.  HD11 cells were plated at 150,000 cells per 
well and challenged with: 
 
1.  Complete media 
2.  0.2 µg/ml crude enzyme rTri101 in complete media 
3.  2 µg/ml crude enzyme rTri101 in complete media 
4.  20 µg/ml crude enzyme rTri101 in complete media 
 
 76
B.    Determine if crude rTri101 conferred protection against T-2 
toxin in vitro when supplemented with acetyl CoA.  HD11 
cells were plated at a density of 150,000 cells per well and 
challenged with: 
1.  Complete media 
2.  0.2 µg/ml crude enzyme rTri101 plus 5 μM acetyl CoA in 
complete media 
3.  0.2 µg/ml crude enzyme rTri101, 5 μM acetyl CoA, and 
0.1 ppm (0.2 µM) T-2 toxin in complete media 
4.  0.1 ppm (0.2 µM) T-2 toxin in complete media 
Statistical analysis 
 Data were analyzed using the MIXED procedure of SAS (SAS, 2006) 
using a Randomized Complete Block design.  Data were blocked on individual 
cell culture plate (random effect).  Cell treatments were declared as fixed effects 
and the dependent variable was the number of live cells per treatment expressed 
as a percent of live control cells set at 100%. Treatment replicates nested within 
plate were declared a random effect.  Differences between means were 
determined using Fisher’s Least Significant Difference test.  Significance was 
declared at p<0.05.   
Results and Discussion 
Experiment 1 Determine the dose of T-2 toxin which caused 50% death of 
HD11 cells 
Incubation of HD11 cells for 18 hours in the presence of 0.1 ppm (0.2 µM) 
T-2 toxin, resulted in a 50% reduction in live cells when compared to controls 
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(53% live verses 100% live respectively; p<0.05; Figure 3.1).  In subsequent 
studies, 0.1 ppm T-2 toxin was used to test for protective effects against T-2 toxin 
as this amount was similar to environmental levels as reported by Gigeous 
(1999).  Calvert and coworkers (2005) similarly reported a 50% survival rate of 
HEp-2 human epithelial cells following a 48 hour exposure to 200 ng/ml (0.2 
ppm) T-2 toxin.  Time and dose trials (data not shown) using 4 to 16 ppm T-2 
toxin in Phosphate Buffered Saline (PBS) for 3 and 4 hour incubations yielded 
unreliable results.  It was concluded 18 hour incubations using 0.1 (0.2 µM) to 1 
ppm (2 µM) T-2 toxin in complete media gave most consistent and repeatable 
data for this study. 
Experiment 2 Test acetyl CoA 
A.)  Acetyl CoA was not toxic to the HD11 cells at any dose tested (5 μM, 10 μM, 
and 25 μM;  Figure 3.2).  The toxicity of acetyl CoA had to be established 
because it has been shown to be necessary for activity of 3-O-acetyltransferase 
in vitro (Kimura et al., 1998a; Kimura et al., 1998b; Kimura et al., 2003).   To 
convert T-2 toxin to 3-O-acetyl T-2 toxin, Kimura and coworkers (1998a) used an 
approximate ratio of 1:2 T-2 toxin to acetyl CoA  (0.4 mM T-2 toxin; 0.8 mM 
acetyl CoA) using a crude enzyme rTri101  preparation from Fusarium 
graminerium.  In other studies, they were able to convert 0.5 mM T-2 toxin to 3-
O-acetyl T-2 toxin using 1 mM acetyl CoA  and crude rTri101 (from Fusarium 
sporotrichioides; Kimura et al., 1998b).  More recently, Kimura and coworkers 
(2003) used this same 1:2 ratio (0.5 mM T-2 toxin; 1 mM acetyl CoA) to convert a  
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Figure 3.1  Percent live HD11 cells challenged with increasing doses of T-2 toxin.  
Results are expressed as percent live cells as a percent of control set to 100%. 
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Figure 3.2  Percent live HD11cells challenged with increasing doses of acetyl 
CoA.  Results are expressed as percent live cells as a percent of control set to 
100%. 
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crude rTri101 preparation (from a Fusarium species that does not produce 
trichothecenes) to 3-O-acetyl T-2 toxin.  These studies provided evidence that 
acetyl CoA was needed in vitro to convert T-2 toxin to the less toxic derivative, 3-
O-acetyl T-2 toxin.   
B.)  Protective effects of acetyl CoA against challenge with T-2 toxin were 
not found (Figure 3.3).   Cell survival when cells were incubated with 0.1 to 1.0 
ppm T-2 toxin and 5 to 25 µM acetyl CoA was not different from T-2 toxin 
treatments (p>0.05).    
Experiment 3 Test rTri101 IB 
A.)  Recombinant Tri101 IB was purified using a mild detergent, Empigen 
BB (Lowhert et al., 1995).  Preliminary results (data not shown) using 4 or 20 nM 
rTri101 IB with empigen yielded low livability (30% and 35% of control, 
respectively).  It was suspected that Empigen BB had toxic effects on the HD11 
cells, so a dose experiment was performed to determine Empigen BB’s toxicity. 
Results (data not shown) indicated that empigen was highly toxic to HD11 
chicken macrophage cells at 0.03%, 0.3% and 3% total volume. Therefore, 
Empigen BB was removed using Detergent-OutTM kit as described in Chapter 2.  
A dose curve of the detergent cleaned rTri101 IB showed it was not toxic at 1 nM 
concentration to HD11 cells (Figure 3.4). 
B.)  Incubation of HD11 cells in the presence of 1 nM rTri101 IB 
supplemented with 5µM acetyl CoA did not protect them from challenge with 0.1 
ppm (0.2 µM) T-2 toxin (43% verses 100% live respectively; Figure 3.5).   
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Figure 3.3  Percent live HD11cells challenged with increasing doses of T-2 toxin and acetyl CoA.  Results are 
expressed as percent live cells as a percent of control set to 100%.  Bars with uncommon letters are different 
(p<0.05). 
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Figure 3.4  HD11 cells incubated with increasing dose of rTri101 IB, following the 
removal of Empigen BB. Results are expressed as percent live cells as a  
percent of control set to 100%. 
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Figure 3.5 Percent live HD11 cells challenged with 0.2 µM T-2 toxin and 
supplemented with 1nM rTri101 IB plus 5 µM acetyl CoA.  Results are expressed 
as percent live cells as a percent of control set to 100%. Bars with uncommon 
letters are different (p<0.05). 
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However, incubation of HD11 cells with both 1 nM rTri101 IB and 5 µM acetyl 
CoA did not prove to be toxic to cells (120% verses 100% live respectively; 
p<0.05).  Empigen BB has been observed to be capable of solublizing proteins 
without altering function (Lowhert et al., 1995).  However, during solubilization 
the detergent may have changed the structure, so it was no longer biologically 
active (Nelson & Cox, 2005).  In studies reported elsewhere, T-2 toxin was 
converted to 3-0-acetyl T-2 toxin prior to in vitro studies  by allowing a 1 hour 
incubation at 37ºC with crude rTri101 (Kimura, et al., 1998a).  Following 
conversion of T-2 toxin to 3-O-acetyl T-2 toxin, both were applied to baby 
hamster kidney (BHK) cells and to rabbit reticulocytes in an in vitro translation 
system. The 3-O-acetyl derivative was less toxic as measured by protein 
synthesis inhibition for both experiments.  In this study rTri101, acetyl CoA, and 
T-2 toxin prepared in RPMI 1640 complete media were immediately applied to 
HD11 cells, and incubated for 18 hours at 39ºC.  Possibly, treatments should 
have been incubated an hour prior to application to HD11 cells for optimal 
protection, and to allow for the acetylation of T-2 toxin.  Otherwise, the 
BCAprotein assay described in Chapter 2 was performed prior to removal of the 
detergent.  During the process of Empigen removal, it was possible that the 
concentration of rTri101 IB was reduced, resulting in inadequate administration of 
rTri101 IB to the HD11 cells when challenged with T-2 toxin.   
Experiment 4 Test rTri101 SF 
A.)    HD11 cells were incubated with increasing doses of rTri101 SF. At 
concentrations of 2 mM or less, rTri101 SF did not have a cytotoxic effect (Figure 
3.6).  
 B.)   Viability of HD11 cells was protected against T-2 toxin when co-
incubated with rTri101 SF supplemented with acetyl CoA.  Percent live cells 
treated with 1 nM rTri101 SF plus 5 μM acetyl CoA and challenged with 0.1 ppm 
(0.2 µM; Test I) T-2 toxin was not different than control cells (p > 0.05), and was 
greater than those incubated with 0.1 ppm (0.2 µM) T-2 toxin alone (p ≤ 0.05; 
Figure 3.7).  Thus, unlike Experiment 3, 1 nM rTri101 SF supplemented with 5 
µM acetyl CoA offered complete protection against 0.1 ppm (0.2 µM) T-2 toxin.   
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Figure 3.6  HD11 cells were incubated with increasing dose of rTri101 SF plus 
acetyl CoA. Results are expressed as percent live cells as a percent of control 
set to 100%. 
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Figure 3.7  Percent live HD11 cells challenged with 1ppm (0.2 µM) T-2 toxin and 
supplemented with 1 nM rTri101 SF plus 5 µM acetyl CoA.   Results are 
expressed as percent live cells as a percent of control set to 100%. Bars with 
uncommon letters are different (p<0.05). 
 
At a higher challenge with 0.5 pppm T-2 toxin (Test II) partial protection was 
observed with 2 nM rTri101 SF supplemented with 10 μM acetyl CoA (Figure 
3.8).  Percent live cells challenged with 0.5 ppm (1 µM) T-2 toxin and co-
incubated with 2 nM rTri101 and 10 µM acetyl CoA was less than controls (83% 
live verses 100% live, respectively; p ≤ 0.05) but greater than cells challenged 
with 0.5 ppm (1 µM) T-2 toxin challenge alone (83% verses 46% live, 
respectively; p ≤ 0.05).  Results from this study are encouraging since T-2 toxin 
levels used in this study are similar to those found on Ames Plantation (Gigeous 
et al., 1999) and indicate rTri101 SF is biologically active. 
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Figure 3.8  Percent live HD11 cells challenged with 0.5 ppm (1 µM) T-2 toxin and 
supplemented with 2nM rTri101 SF plus 10 µM acetyl CoA.   Results are 
expressed as percent live cells as a percent of control set to 100%. Bars with 
uncommon letters are different (p<0.05). 
 
In test III, HD11 cells were challenged with higher levels of T-2 toxin.  
Cells were challenged with 1 ppm (2 µM) T-2 toxin and supplemented with 1 nM 
rTri101 SF plus 5 μM acetyl CoA.  At this level T-2 toxin (1 ppm), protective 
effects of rTri101 SF plus acetyl CoA supplementation (52% live) were not 
observed as compared to T-2 toxin alone (47% live; p>0.05; Figure 3.9).  To 
determine if greater amounts of rTri101 SF were needed for protection at this 
level of T-2 toxin, the dose of rTri101 was increased 5 fold to 5 nM rTri101 SF 
plus a 5 fold increase in acetyl CoA, 25 μM (Test IV).  When combined with 1 
ppm (2 µM) T-2 toxin, 5 nM rTri101 SF plus 25 µM acetyl CoA had partial 
protective effects against T-2 (66% verses 36% live respectively; p<0.05; Figure 
3.10).  These results were expected because in Experiment 4A, 5 nM rTri101 SF  
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Figure 3.9  Percent live HD11 cells challenged with 1 ppm (2 µM) T-2 toxin and 
supplemented with 1 nM rTri101 SF plus 5 µM acetyl CoA.   Results are 
expressed as percent live cells as a percent of control set to 100%.  Bars with 
uncommon letters are different (p<0.05) 
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Figure 3.10  Percent live HD11 cells challenged with 1 ppm (2 µM) T-2 toxin and 
supplemented with 5 nM rTri101 SF plus 25 µM acetyl CoA.   Results are 
expressed as percent live cells as a percent of control set to 100%. Bars with 
uncommon letters are different (p<0.05). 
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plus 25 µM acetyl CoA was toxic to cells (57% verses 100% live; p<0.05; Figure 
3.6).  Thus, a threshold must exist for rTri101 SF to confer protection against T-2 
toxin on HD11 cells.  Binding sites located on rTri101 for trichothecenes as 
described by Garvey and coworkers (2007) allow for hydrophobic bonding 
between rTri101 and trichothecenes during conversion to less toxic 
intermediates.   Protective effects of rTri101 may be due to availability of binding 
sites and explain the lower level of protection observed in Test IV of this 
experiment.    
Experiment 5 Test crude rTri101 
 A.)  The final experiment sought to test the effects of a crude enzyme 
preparation of rTri101 against T-2 toxin, and to replicate Kimura and coworkers’ 
(1998) experiment.  Increasing doses of crude rTri101 were incubated with HD11 
cells.  At a total protein concentration of 0.2 μg/ml or less, the enzyme was not 
toxic (Figure 3.11).  This was not representative of the amount of rTri101, as the 
crude preparation included multiple other proteins as was seen in Figure 2.11.   
B.) Tests for protective effects of the crude rTri101 showed there was no 
protection against 0.1 ppm (0.2 µM) T-2 toxin (Figure 3.12).  Cells treated with 
0.2 µg/ml crude rTri101 plus 5µM acetyl CoA were not different than controls 
(83% verses 100% live respectively; p≥0.05).  However when cells were 
challenged with 0.1 ppm T-2 toxin and supplemented with 0.2 µg/ml crude  
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Figure 3.11  HD11 cells incubated with increasing doses of crude rTri101  
Results are expressed as percent live cells as a percent of control set to 100%. 
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Figure 3.12  Percent live HD11 cells challenged with 0.1 ppm (0.2 µM) T-2 toxin 
and supplemented with 0.2 µg/ml crude rTri101 plus 5 µM acetyl CoA.   Results 
are expressed as percent live cells as a percent of control set to 100%. Bars with 
uncommon letters are different (p<0.05). 
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rTri101 plus 5 µM acetyl CoA, no protection was observed, and percent live was 
not different than those challenged with T-2 toxin alone (50% verses 59% live 
respectively; p>0.05).  Like other bacterial cells, JM109 cells used for the 
expression of rTri101 contain lipopolysaccharide (LPS; Amro et al., 2000).  LPS 
are membrane proteins of gram negative bacterial cell walls which cause an 
immune response by up regulating the production of cytokines.  LPS causes the 
activation of macrophage cells, and the production of nitric oxide which promotes 
antimicrobial properties of macrophages and also combines with superoxide 
anions to become more potent antimicrobial agents (Holst 1996; Goldsby, et al., 
2003).  LPS has been shown to up regulate nitric oxide peritoneal macrophages 
from C3H/He and C3H/HeJ mice and in rat Kupffer cells (Steuhr et al., 1985; 
Rietschel et al., 1996).  In HD11 cells, following an initial endotoxin challenge, 
nitric oxide was induced, but in subsequent challenges, nitric oxide was no longer 
up regulated indicating a refractory period of endotoxin tolerance (Chang et al., 
1996).  Since the crude enzyme fraction in Experiment 5 was not purified, it 
contained many proteins, probably including LPS.  Thus, when T-2 toxin was 
added to cells already activated by endotoxin, additional cell death occurred 
because HD11 cells unable to respond to any additional stress (Goldsby et al., 
2003).  
Conclusion 
 Results from these experiments indicate that biologically active rTri101 SF 
had significant protective effects against T-2 toxin in vitro.  However, 
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trichothecene binding sites located on rTri101 may be a limiting factor in 
protection against higher amounts of T-2 toxin.  Potentially, incorporation of the 
isolated gene product in poultry feeds may serve to protect animals against 
trichothecene poisoning.  Further experiments using rTri101 will determine it’s 
ability to provide protection against trichothecene mycotoxins in vivo and may 
prove of importance to the poultry industry.   
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4. Conclusion 
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The goals of this study were to produce and isolate the tri101 gene 
product, trichothecene-3-O-acetyltransferase (rTri101). Further, the aim was to 
determine if tri101 conferred protective effects against T-2 toxin on HD11 chicken 
macrophage cells. Experiments were performed in different chronological order 
than presented in this thesis. Recombinant Tri101 IB was produced first and in 
vitro experiments were conducted on it’s in vitro protective effects. When rTri101 
IB proved unsuccessful, crude rTri101 was produced similar to the protocol 
published by Kimura and coworkers (1998). Crude rTri101 was also observed not 
to confer protective effects in vitro. Lastly, rTri101 SF was produced. In vitro 
experiments determined that some levels of therTri101 SF conferred protective 
effects against T-2 toxin.  The protective effects were greatest with the ratio of 
rTri101 to T-2 toxin was 1:200. 
T-2 toxin interacts with peptidal transferase and exerts its detrimental 
effects by inhibiting protein, DNA, and RNA synthesis (Wei et al., 1974).  For this 
reason, T-2 toxin affects rapidly dividing cells such as those of the intestines, 
spleen, thymus, testes, and lymphatic system (Ueno, 1977).  HD11 chicken 
macrophage cells were therefore well suited to test for protective effects against 
T-2 toxin.  Poultry are sensitive to T-2 toxin.  Symptoms of T-2 toxicosis in poultry 
include oral lesions, neural abnormalities, altered feathering, decreased body 
weight gain, and decreased egg production (Wyatt et al., 1972; Wyatt et al., 
1973a; Wyatt et al., 1973b; Wyatt et al., 1975a; Wyatt et al., 1975b).  Numerous 
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attempts have been made to alleviate the effects of T-2 toxin in chickens 
(Chowdhury and Smith, 2005; García et al, 2003; Kubena et al., 1998; (Kubena 
et al., 1990).  However, none have been successful.   
 Tri101 may be the solution to the T-2 toxin problem.  Tri101 reduces the 
toxicity of T-2 toxin by inserting an acetyl group on C3.  It was speculated the 
addition of this acetyl group changed the spatial arrangement of T-2 toxin's the 
most toxic component, the 12, 13 epoxytrichothecene ring (Grizzle, 2007; 
Bamburg et al., 1968).  Therefore, T-2 toxin was rendered less toxic.  The 
purification of rTri101 is only the first step in the long pathway to produce a feed 
additive or drug that may reduce the toxicity of T-2 toxin. Recombinant Tri101 
protected HD11 cells against T-2 toxin. If rTri101 is successful in vivo, there are 
possibilities for its use as a therapeutic drug. Since the approval of the first 
recombinant protein therapeutic drug, Humulin, in 1982, 40 recombinant proteins 
have been approved for therapeutic use in the US (Reichert, 2003).  In 2003, 
estimates quoted recombinant DNA technologies to represent over $32 billon 
dollars in the human medical biotechnology industry. This estimate is expected to 
grow larger by 2010 (Pavlou & Reichert, 2004). Recombinant Tri101 may 
ultimately serve as safe, non-invasive method to effectively control the 
detrimental effects of mycotoxins for humans and animals. 
 98
References 
 
Bamburg, J. R., Riggs, N. V., and Strong, F. M. (1968). The structures of toxins 
from two strains of Fusarium tricinctum. Tetrahedron 24, 3329-3336. 
 
Chowdhury, S. R., and Smith, T. K. (2005). Effects of feeding grains naturally 
contaminated with Fusarium mycotoxins on hepatic fractional protein 
synthesis rates of laying hens and the efficacy of a polymeric 
glucomannan mycotoxin adsorbent. Poult Sci 84, 1671-1674. 
 
García, A. R., Avila, E., Rosiles, R., and Petrone, V. M. (2003). Evaluation of two 
mycotoxin binders to reduce toxicity of broiler diets containing ochratoxin 
A and T-2 toxin contaminated grain. Avian Dis 47, 691-699. 
 
Grizzle, J. M. (2007). Professor, Department of Animal Science, University of 
Tennessee. (P. Communication, Ed.), Knoxville. 
 
Kimura, M., Kaneko, I., Komiyama, M., Takatsuki, A., Koshino, H., Yoneyama, 
K., and Yamaguchi, I. (1998). Trichothecene 3-O-acetyltransferase 
protects both the producing organism and transformed yeast from related 
mycotoxins. Cloning and characterization of Tri101. J Biol Chem 273, 
1654-1661. 
 
Kubena, L. F., Harvey, R. B., Bailey, R. H., Buckley, S. A., and Rottinghaus, G. 
E. (1998). Effects of a hydrated sodium calcium aluminosilicate (T-Bind) 
on mycotoxicosis in young broiler chickens. Poult Sci 77, 1502-1509. 
 
Kubena, L. F., Harvey, R. B., Huff, W. E., Corrier, D. E., Phillips, T. D., and 
Rottinghaus, G. E. (1990). Efficacy of a hydrated sodium calcium 
aluminosilicate to reduce the toxicity of aflatoxin and T-2 toxin. Poult Sci 
69, 1078-1086. 
 
Pavlou, A. K., and Reichert, J. M. (2004). Recombinant protein therapeutics--
success rates, market trends and values to 2010. Nat Biotechnol 22, 
1513-1519. 
 
Reichert, J. M. (2003). Trends in development and approval times for new 
therapeutics in the United States. Nat Rev Drug Discov 2, 695-702. 
 
Ueno, Y. (1983). Trichothecenes- Chemical, Biological, and Toxicological 
Aspects. Elsevier Science Publishing Company, New York. 
 
 99
Wei, C. M., Hansen, B. S., Vaughan, M. H., Jr., and McLaughlin, C. S. (1974). 
Mechanism of action of the mycotoxin trichodermin, a 12,13-
epoxytrichothecene. Proc Natl Acad Sci U S A 71, 713-717. 
Wyatt, R. D., Weeks, B. A., Hamilton, P. B., and Burmeister, H. R. (1972). 
Severe oral lesions in chickens caused by ingestion of dietary fusariotoxin 
T-2. Appl Microbiol 24, 251-257. 
 
Wyatt, R. D., Colwell, W. M., Hamilton, P. B., and Burmeister, H. R. (1973a). 
Neural disturbances in chickens caused by dietary T-2 toxin. Appl 
Microbiol 26, 757-761. 
 
Wyatt, R. D., Hamilton, P. B., and Burmeister, H. R. (1973b). The effects of T-2 
toxin in broiler chickens. Poult Sci 52, 1853-1859. 
 
Wyatt, R. D., Hamilton, P. B., and Burmeister, H. R. (1975a). Altered feathering 
of chicks caused by T-2 toxin. Poult Sci 54, 1042-1045. 
 
Wyatt, R. D., Doerr, J. A., Hamilton, P. B., and Burmeister, H. R. (1975b). Egg 
production, shell thickness, and other physiological parameters of laying 
hens affected by T-2 toxin. Appl Microbiol 29, 641-645.
 100
 
 
 
 
Appendix 
 101
Appendix A 
JM109 Competent Cell Transformation Protocol 
 
Materials  
 
JM109 Competent Cells (Promega L2001, Madison WI) 
SOC medium  
LB plates with antibiotic  
Falcon 17 × 100mm polypropylene culture tubes (Fisher 14-959-10B,  
Atlanta GA) 
Bacto®-tryptone (BD Biosciences, 211705) 
Bacto®-yeast extract (BD Biosciences 210929) 
Ampicillin (Sigma A0166-5G); made into 50 µg/ml stock 
AccuSpin MicroR MicroCentrifuge (Fisher, 13100511) 
Glucose (Sigma G5767, St Louis, MO) 
Petri Dishes (Fisher 0875712, Atlanta, GA) 
LB Agar (Fisher BP1425-500 Atlanta, GA) 
 42°C gyratory water bath 
  
 
Solutions 
 
Glucose, 2M 
Weigh 180.16g glucose (C6H12O6; F.W. 181.16) 
Add distilled water until final volume is 500ml 
Filter-sterilize through a 0.2µm filter unit  
Store in aliquots at -20°C.  
 
50 mg/ml Ampicillin Stock 
Measure 0.5 g Ampillicin 
Add to 10 ml ddH20 
Vortex until completely mixed 
Filter-sterilie through a 0.45 µm filter unit 
Store in 1 ml aliquots at -20ºC 
 
LB Agar plates supplemented with Ampicillin 
500 mL dd H20 
 20 g LB Agar 
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 Autoclave for 20 minutes 
 Cool to 55ºC  
Add 1 ml of 50 mg/mL Ampicillin stock 
 Pour plates 
 
Mg2+ stock solution, 2M 
Weigh 101.5g MgCl2  
Weigh 123.3g MgSO4  
Combine and Add distilled water until final volume is 500ml 
Fillter-sterilize through a 0.2µm filter unit. 
 
SOC medium 
2.0g Bacto®-tryptone 
0.5g Bacto®-yeast extract 
1ml 1M NaCl 
0.25ml 1M KCl 
1ml Mg2+ stock, filter-sterilized 
1ml 2M glucose, filter-sterilized 
Bring to 100ml volume with distilled water. 
Add Bacto®-tryptone, Bacto®-yeast extract, NaCl and KCl to 97ml distilled water. 
Stir to dissolve. Autoclave and cool to room temperature. Add 2M Mg2+ stock 
and 2M glucose stock, each to a final concentration 20mM adjust pH to 7.0.  
Filter the complete medium through a 0.2µm filter unit.  
 
Procedure 
 
1. Chill sterile 17 × 100mm polypropylene culture tubes on ice, one per 
transformation (e.g., Falcon. 2059).  
 
2. Remove frozen Competent Cells from -70°C and place on ice for 5 minutes, or 
until just thawed. Once the cells have thawed, pipet quickly or use chilled (4°C) 
pipette tips to prevent the cells from warming above 4°C. 
 
3. Gently mix the thawed Competent Cells by tapping the tube, and transfer 
50 µl to the chilled culture tube. 
 
4. Add 1 µl pUCSVTri101 (the concentration was unknown) to 50 µl of 
Competent Cells. Move the pipette tip through the cells while dispensing.  
Quickly mix the tube by tapping the side. 
 
5. Immediately return the tubes to ice for 10 minutes. 
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6. Heat-shock the cells for exactly 45 seconds in a water bath at exactly 42°C.  
Do not shake. 
 
7. Immediately place the tube on ice for 2 minutes. 
 
8. Add 950µl of cold (4°C) SOC medium to each transformation reaction, and 
incubate for 90 minutes at 37°C with shaking (approximately 225rpm). 
 
9. For each transformation reaction, it was recommend diluting the cells 1:10 and 
1:100 and plating 100µl of the undiluted, 1:10 and 1:100 dilutions on antibiotic 
plates. Incubate the plates at 37°C for 12-14 hours. 
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Appendix B 
Plasmid DNA Purification Using the 
QIAprep Spin Miniprep Kit 
 
Materials  
 
LB Broth (Fisher BP1426-500 Atlanta, GA) 
Ampicillin (Sigma A0166-5G); made into 50 µg/ml stock 
AccuSpin Micro R MicroCentrifuge (Fisher, 13100511 Atlanta, GA) 
1.5 ml Eppendorf tubes (Fisher 05408429 Atlanta, GA) 
QIAprep Spin Miniprep Kit (QIAGEN, 27106 Valencia, CA) contains: 
Buffer P1 
Buffer P2 
Buffer N3 
Buffer PB 
Buffer PE 
Buffer EB 
LyseBlue 
RNase A 
2 ml collection tubes 
Solutions 
LB Broth 
 500 mL dd H20  
 12.5 g LB Broth (powder) 
 Autoclave for 20 minutes 
 Cool to 55ºC 
 Add 1 ml of 50 μg/mL Ampicillin (final concentration 100 µg/ml) 
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Procedure 
1. Grow transformed JM109 cells containing pUCSVtri101 in LB plus ampillicin 
media overnight at 37ºC in a shaking water bath.  Remove 1 ml of overnight 
culture.  Centrifuge at 13,000 rpm (16,000 x g) for 1 minute at room temperature. 
 
2.  Resuspend pelleted bacterial cells in 250 μl Buffer P1 and transfer to the 
microcentrifuge tube. 
 
3. Add 250 μl Buffer P2 and mix thoroughly by inverting the tube 4–6 times. 
Mix gently by inverting the tube. Do not vortex. 
 
4. Add 350 μl Buffer N3 and mix immediately and thoroughly by inverting the tube 
4–6 times. 
 
5. Centrifuge for 10 minutes at 13,000 rpm (~16,000xG) in a table-top 
microcentrifuge.   
 
6. Apply the supernatants from step 4 to the QIAprep spin column by decanting 
or pipetting. 
 
7. Centrifuge at 13,000 RPM (~16,000 x g) for 30–60 seconds. Discard the flow-
through. 
 
8. Wash the QIAprep spin column by adding 0.5 ml Buffer PB and centrifuging 
at13,000 RPM (~16,000 x g) for 30–60 seconds Discard the flow-through. 
 
9. Wash QIAprep spin column by adding 0.75 ml Buffer PE and centrifuging at 
13,000 RPM (~16,000 x g) for 30–60 seconds 
 
10. Discard the flow-through, and centrifuge at 13,000 RPM (~16,000 x g) for an 
additional 1 minute to remove residual wash buffer. 
 
11. Place the QIAprep column in a clean 1.5 ml microcentrifuge tube. To elute 
DNA, add 50 μl H20 to the center of each QIAprep spin column, let stand for 1 
minute, and centrifuge at 13,000 RPM (~16,000 x g)for 1 minute. 
 
Note: All protocol steps should be carried out at room temperature. 
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Appendix C 
Gel Electrophoresis 
 
Materials  
 
Agarose Gel (Fisher BP1356-500, Atlanta, GA)) 
1Kb Ladder (Promega G571A, Madison, WI) 
Blue Orange 6x Loading Buffer (Promega G190A, Madison, WI) 
50x Tris/Acetic Acid/EDTA (TAE) Buffer (BioRad 161-0743, Hercules, CA) 
10 mg/ml Ethidium Bromide (BioRad 161-0433; Hercules, CA; wear gloves 
because Ethidium Bromide is a carcinogen) 
Alpha Innotek FluorChemTM 5500 (AlphaInnoTek 5500, San Leandro, CA) 
 
Solutions 
 
1x TAE Buffer 
Mix 49 parts water with 1 part 50X TAE Buffer (final concentration will be 
40 mM Tris, 20 mM acetic acid, and 1 mM EDTA (pH 8.0)) 
 
Procedure 
 
For an 0.8% concentration: 
 
1. Measure 50 mL 1X TAE Buffer into a 125 mL glass bottle 
 
2. Measure 0.4 g Agarose and add to 1X TAE buffer 
 
3. Place in Microwave for 1 minute 
a. Watch solution to ensure that it does not boil over 
 
4. Allow solution to cool on bench for 2-3 minutes 
 
5. Add 5 μl of 10 mg/ml Ethidium Bromide  
 
6. Mix solution by swirling 
 
7. Pour slowly into gel tray 
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8. Add comb 
 
9. Wait 15-20 minutes for gel to become firm 
 
10. Release gel from vice 
 
11. Place tray in electric field filled with 1X TAE buffer 
 
12. Ensure gel is completely covered with 1X TAE buffer 
 
13. Load reagents 
a. Load 5 μl of the 1 Kb ladder  
b. Mix 5 μl of each sample to 1 μl of Blue Orange 6x Loading Buffer 
 
14. Place electrodes onto apparatus (positive to positive and negative to 
negative) so DNA will migrate toward the positive (red) node 
 
15. Run gel100 volts of constant voltage for 30 minutes  
 
16. Remove electrodes from apparatus 
 
17. Remove gel 
 
18. Take picture using transilluminating filter of the Alpha Innotek FluorChem 
5500 
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Appendix D 
PCR Reaction with pUCSVtri101 
Materials 
Forward primer (Integrated DNA Technologies, Skokie, IL) 
Reverse primer (Integrated DNA Technologies, Skokie, IL)  
Distilled, deionized H20  
Taq DNA polymerase 10x Reaction Buffer without MgCl2 (Promega 
M190G, Madison, WI)  
MgCl2 (Promega A351H, Madison, WI) 
dNTP (Promega C114G, Madison, WI)  
Taq DNA Polymerase in Storage Buffer B (Promega M166B, Madison,  
WI) 
0.2 ml PCR Tubes (Fisher E0030 124 260, Atlanta GA) 
Eppendorf Mastercycler (Fisher S65955, Atlanta GA) 
 
Solutions  
Reaction consisted of: 
 
5 μL whole cell pUCSVtri101 (unknown concentration) 
4 μL 5 pM/µl forward primer  
4 μL 5 pM/µl reverse primer   
64 μL distilled, deionized H20  
10 μL Taq DNA Polymerase 10x Reaction Buffer without MgCl2
10 μL MgCl2 (final concentration 1.5 mM) 
2 μL dNTP  
1 μL Taq DNA Polymerase in Storage Buffer B 
100 μL 
 
5 μL reconstituted pUCSVtri101 (unknown concentration) 
4 μL 5 pM/µl forward primer  
4 μL 5 pM/µl reverse primer   
64 μL distilled, deionized H20  
10 μL Taq DNA Polymerase 10x Reaction Buffer without MgCl2
10 μL MgCl2 (final concentration 1.5 mM) 
2 μL dNTP  
1 μL Taq DNA Polymerase in Storage Buffer B 
100 μL 
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Procedure 
 
Thermocycler settings started with 5 minutes at 95ºC  then 33 repetitions 
of rotating intervals of 30 seconds at 95ºC to denature, 30 seconds at 55ºC to 
anneal, and 90 seconds at 72ºC for extension 
 
 110
Appendix E 
QIAquick PCR Purification Kit Protocol 
 
Materials 
 
AccuSpin MicroR Microcentrifuge (Fisher, 13100511, Atlanta, GA) 
QIAquick PCR Purification Kit (QIAGEN, 28106 Valencia, CA) contained: 
QIAquick Spin Columns 
Buffer PBI 
Buffer PE (concentrate) 
Buffer EV 
2 ml collection tubes 
 
Procedure 
 
1. Add 500 µl of Buffer PBI to 100 µl of the PCR sample and mix.  
 
2. Check that the color of the mixture is yellow (similar to Buffer PBI without the 
PCR sample). If the color of the mixture is orange or violet, add 10 μl of 3 M 
sodium acetate, pH 5.0, and mix. The color of the mixture will turn to yellow. 
 
3. Place a QIAquick spin column in a provided 2 ml collection tube. 
 
4. To bind DNA, apply the sample to the QIAquick column and centrifuge at 
13,000 RPM (~16,000 x g) for 30–60 seconds 
 
5. Discard flow-through. Place the QIAquick column back into the same tube. 
Collection tubes are re-used to reduce plastic waste. 
 
6. To wash, add 0.75 ml Buffer PE to the QIAquick column and centrifuge at 
13,000 RPM (~16,000 x g) for 30–60 seconds 
 
7. Discard flow-through and place the QIAquick column back in the same tube. 
Centrifuge at 13,000 RPM (~16,000 x g)the column for an additional 1 min.  
 
8. Place QIAquick column in a clean 1.5 ml microcentrifuge tube. 
 
9. To elute DNA, add 50 μl ddH20 to the center of the QIAquick membrane and 
centrifuge the column at 13,000 RPM (~16,000 x g) for 1 minute.  
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IMPORTANT: Ensure that the elution buffer is dispensed directly onto the 
QIAquick membrane for complete elution of bound DNA.  
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Appendix F 
Digestion of tri101 from PCR amplified pUCSVtri101 
using Bam HI and Hind III 
 
Materials 
ddH20 
10x Buffer E (Promega R005A, Madison, WI 
Amplified, extracted, and purified tri101 (60 ng/ml) 
10 units/μL Bam HI (Promega R602A, Madison, WI) 
10 units/μL Hind III (Promega R604A, Madison, WI)   
1.5 ml Eppendorf Tubes (Fisher 05408129, Atlanta, GA) 
 
Procedure 
The digestion was completed using the following reaction: 
 
 
37 μL distilled, deionized H20 (ddH20) 
  8 μL of 10x Buffer E (Promega R005A, Madison, WI)   
35 μL of amplified, extracted, and purified 60 ng/µl tri101  
  4 μL of 10 units/μL Bam HI (Promega R602A, Madison, WI)  
  4 μL of 10 units/μL Hind III (Promega R604A, Madison, WI)   
     88 μL Total 
 
Solutions were placed into 1.5 ml eppendorf tubes and incubated for 2 hours 
in a 37ºC water bath. 
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Appendix G1 
Ligation of tri101 into pQE30 
 
 
Materials 
Digested (Bam HI, Hind III), purified tri101 gene product (60 µg/ml) 
pQE30 (QIAGEN 32915, Valencia, CA) 
2x ligation buffer (Promega C6713, Madison, WI) 
T4 ligase (Promega, M180a, Madison, WI)  
1.5 ml Eppendorf tubes (Fisher 05408129, Atlanta, GA) 
Procedures 
The reaction consisted of:  
 
• 2 μL of 30 ng/µl pQE30 (QIAGEN 32915, Valencia, CA) 
• 2 μL digested, purified 60 ng/µl tri101 gene product  
• 5 μL of 2x ligation buffer (Promega C6713, Madison, WI) 
• 1 μL of T4 ligase (Promega, M180a, Madison, WI)  
          10 μL total 
  
and was incubated at room temperature for 2 hours. 
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Appendix G2 
JM109 Competent Cell Transformation Protocol 
 
Corresponds to Appendix A except for the following changes:   
 
Step 3  Gently mix the thawed Competent Cells by tapping the tube, and transfer 
100 µl to the chilled culture tube. (instead of 50 µl in Appendix A) 
 
Step 8  Add 900µl of cold (4°C) SOC medium (instead 950 µl in Appendix A) to 
each transformation reaction, and incubate for 90 minutes at 37°C with shaking 
(approximately 225rpm). 
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Appendix H 
PCR was completed to amplify the 4 pQE30 plasmids that 
accepted tri101 
 
 
Appendix D with the following changes: 
Use 5 µl of pQEtri101 (instead of pUCSVtri101 in Appendix D) in the reaction
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Appendix I 
Digestion of pQEtri101 with Bam HI and Hind III 
 
Appendix F with the following changes: 
 
• 13 μL distilled, deionized H20  
• 2 μL of 10x Buffer (Promega R005A, Madison, WI)   
• 5 μL pQEtri101  
• 5 μL Bam HI (Promega R602A, Madison, WI)  
• 5 μL of Hind III (Promega R604A, Madison, WI)   
     30 μL total 
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Appendix J 
SDS PAGE 
 
Materials: 
 
Mini Protean Tetra Cell (BioRad 165-8002, Hercules CA) 
44 mM Ammonium persulfate (BioRad 161-0700 Hercules, CA) 
30 % bisacrylamide (BioRad 161-0436) 
0.5 and 1.5 M Tris-HCl (Fisher, BP 153-1 Atlanta, GA) 
Isobutanol (Fisher AA36643K7, Atlanta, GA) 
1N HCl (Fisher, A485-212 Atlanta, GA) 
Tris Base (Fisher, BP 152-5 Atlanta, GA) 
Glycine (Fisher BP 381-5 Atlanta, GA) 
SDS (Fisher BP 166500 Atlanta, GA) 
≥ 99.9% Methanol (Fisher, BP 1105-4 Atlanta, GA) 
99.7+% Acetic Acid  C2H4O2  (Fisher AC423220025, Atlanta, GA) 
β-mercaptolethanol (Fisher BP 176-100 Atlanta, GA) 
Commassie Blue R-250 (Fisher BP 161-0400 Atlanta, GA) 
TEMED (Fisher BP 150-20 Atlanta, GA) 
 Loading Tips (Fisher 05408154, Atlanta, GA) 
AccuSpin MicroR Microcentrifuge (Fisher 13100511, Atlanta GA) 
Alpha Innotek FluorChemTM 5500 (AlphaInnoTek 5500, San Leandro,  
CA) 
 
Solutions  
 
44 mM Ammonium persulfate ((NH4)2S2O8; F.W. 228.2) 
1g ammonium persulfate  
10 mL dd H2O 
 Aliquot into 0.5 mL fractions and freeze at -20C 
 
Separating gel buffer- 1.5 M Tris-HCl, pH 8.8 
 27.23 g Tris Base  (H2NC(CH2OH)3·HCl; C4H11NO3·HCl; F.W. 157.60) 
80 mL dd H2O. 
Tritrate with 1N HCl to pH 8.8.  
Add dd H20 to desired final volume of 150 mL 
 
Stacking gel buffer 0.5 M Tris-HCl, pH 6.8 
 6 g Tris Base (H2NC(CH2OH)3·HCl; C4H11NO3·HCl; F.W. 157.60)  
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60 mL dd H2O 
Tritrate with 1N HCl to pH 6.8  
Add dd H20 to desired final volume of 100 ml 
 
10X Running Buffer 
 Tris Base 30g 
 Glycine 144 g 
 SDS  10 g 
 Add dd H2O to final volume of 1 Liter 
 To dilute to 1X by adding 900 mL dd H2O to 100 mL 10X Running  
Buffer 
 
Staining Solution 
 Methanol          500 ml 
 Acetic Acid          100 ml 
 dd H2O          400 ml 
 Commassie Blue R-250      2 g 
   Total         1 Liter 
 
Destaining Solution 
 Methanol 500 mL 
 Acetic Acid 100 mL 
 dd H2O 400 mL
  Total 1 Liter 
 
 
2X Loading Buffer 
 0.5 M Tris-HCl, pH 6.8     2.5 ml 
 Glycerol    2 ml 
 10 % SDS    4 ml 
 β-mercaptolethanol   1 ml 
   Total         9.5 ml 
 
Water-saturated Isobutanol 
Shake equal volumes of water and isobutanol ((CH3)2CHCH2OH; 
F.W. 74.12) in a glass bottle   
Allow to separate.  
Use the top layer.  
Store at -4º 
 
Separating Gel 
dd H20     3.35 ml 
1.5% Tris HCl at pH 8.8        2.5 ml  
10% SDS     100 μl 
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Acrylamide Bis (30%)    4.0 ml 
Ammonium Persulfate    40 μl 
TEMED         5 μl
Total  10 ml  
 
Stacking Gel 
dd H20      6.1 ml 
0.5% Tris HCl at pH 6.8    2.5 ml 
10% SDS     100 μl 
           Acrylamide Bis (30%)    1.3 mL 
*Stop at this step (because gel will set so quickly after addition of 
Ammonium Sulfate and TEMED, wash the water-saturated 
isobutanol off the top of the cassette before adding Ammonium 
Persulfate to the solution) 
 Decant water saturated  
Isobutanol from top of gel cassette 
 Rinse cassette with dd H20  
at least 3 times 
Ammonium Persulfate      40 μL 
TEMED      10 μL 
  Total   10 ml 
 
 
Procedure 
 
SDS PAGE 
1. Prepare 10% Separating Gel 
 
2. Place glass cassette into casting stands 
 
3. Load into glass cassette using 5 mL pipette  
a. Fill until about ½ to ¾ inch below top of cassette to account for 
stacking gel 
 
4. Add ~ 1mL water saturated isobutanol 
 
5. Ensure no bubbles are present 
 
6. Allow get to set for 45 minutes 
 
7. Prepare stacking gel 
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8. Add ~ 1 mL stacking gel to glass cassette to fill 
 
9. Ensure no bubbles are present 
 
10. Push comb into place 
 
11. Let stacking gel set for 45 minutes 
 
12. Meanwhile prepare samples for loading 
 
13. Remove samples containing 2X loading buffer from -20C freezer 
 
14. Place in floater 
 
15. Boil for 5 minutes 
 
16. Microcentrifuge for 10 seconds 13,000 RPM (~16,000 x g) 
 
17. Remove glass cassettes from the gel casting stands 
 
18. Place glass cassettes into casting frames 
 
19. Place casting frames with glass cassettes in electrode apparatus 
 
20. Fill portion between glass cassettes almost full with Running Buffer 
a. Ensure to fill to above beginning of gel portion, but below top of 
cassette 
 
21. Add running buffer to running apparatus to fill it ~ 1/3 full 
 
22. Remove gel comb 
 
23. Using loading tips, 10 μL of each sample was loaded into each lane 
 
24. Place the lid on the apparatus by positioning the positive (red) electrodes 
together and the negative (black) electrodes together 
 
25. Set machine to 200 volts for 45 minutes at 3.0 Amps 
 
26. Push start 
 
27. Wait 45 minutes 
 
28. Remove glass cassette 
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29. Decant running buffer 
 
30. Separate the glass cassettes using plastic spatula 
 
31. While gel is still attached to one piece of glass, cut off stacking gel portion 
with the spatula 
 
32. Place gel into staining solution and shake for 1 hour at room temperature 
 
33. Move gel to destaining solution and shake for 1 hour at room temperature 
 
34. Move gel to distilled H20 overnight at room temperature 
 
35. Take picture of gel using fluorescent filter of FluorChem 5500 
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Appendix K 
Purification of tri101 from inclusion bodies 
Materials 
5M NaCl (Fisher BP305-212 Atlanta, GA)  
1M Imidazole (Fisher BP305-50 Atlanta, GA) 
50 mM Sodium Phosphate (Fisher BP 330-1 Atlanta, GA) 
 6 M HCl (Fisher SA48-1 Atlanta, GA) 
10% Glycerol (Fisher BP 229-1 Atlanta, GA) 
30% Empigen BB Detergent (Calbiochemical 324690, San Diego, CA) 
 LB Broth (Fisher BP1426-500 Atlanta, GA) 
 LB Agar (Fisher BP1425-500 Atlanta, GA) 
 50 mg/ml Ampicillin (Sigma A0166-5G, St Louis, MO) 
JM109 Competent Cells (Promega L2001 Madison, WI) 
 Ni-NTA Agarose (Qiagen 30230 Valencia, CA) 
 5 mL Polypropylene Columns (Qiagen 34964 Valencia, CA) 
β-mercaptolethanol (Fisher BP 176-100 Atlanta, GA) 
500 ml Centrifuge bottle (Fisher 14-375-355, Atlanta GA) 
 Distilled, deionized water  
Isopropyl β-D-thiogalactopyranoside (IPTG; Sigma, I5502-1G St Louis, 
MO) 
 10X PBS (Sigma P5493, St Louis, MO) 
 10 mg/ml Lysozyme  (Sigma L3790, St Louis, MO) 
Innoculating loops (Fisher 13-075-2 Atlanta, GA) 
Beckman Centrifuge (Beckman Coulter J2-HS, Fullerton, CA) 
Jouan Centrifuge (ThermoScientific CR312, Atlanta, GA) 
Sonic Dismembrator (Fisher 1533853, Atlanta GA) 
1.5 ml Eppendorf tubes (Fisher 05408129, Atlanta, GA) 
15 ml Graduated Tubes Fisher 05-538-59B, Atlanta, GA) 
 Falcon 5 ml Polysterene Round Bottom Tubes (Fisher 14-959-1A,  
Atlanta, GA) 
100 O.D. x 15mm H Petri Dishes (Fisher 0875712, Atlanta, GA) 
 Isotemp Refridgerator (Fisher 13-986-106A, Atlanta GA) 
 5.7 x 93.5 mm 30 ml Nalgene Polypropylene Centrifuge Tubes (Fisher  
  5291C, Atlanta, GA) 
Solutions 
 
1X PBS 
Dilute 1 part 10X PBS with 10 parts ddH20 
 
LB Broth 
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 500 mL dd H20  
 12.5 g LB Broth (powder) 
 Autoclave for 20 minutes 
 Cool to 55ºC 
 Add 1 ml of 50 μg/mL Ampicillin  
 
LB Agar plates 
500 mL dd H20 
 20 g LB Agar 
 Autoclave for 20 minutes 
 Cool to 55ºC  
Add 1 ml of 50 mg/mL Ampicillin  
 Pour plates 
 
IPTG (100 mM) 
 40 mL dd H20  
Add 1.19 g isopropyl β-D-thiogalactopyranoside  
Adjust volume to 50 ml with dd H20 
Divide in 5 ml aliquots and sterilize by filtration with 0.2 µm filter unit 
Store at -20ºC (stable for 2-4 months) 
  
Lysis buffer 
 50 mM Sodium Phosphate (NaH2PO4 · H2O; F.W. 137.99) 
 300 mM NaCL (NaCl; F.W. 58.44) 
 20 mM Imidazole (HNCH:CHN:CH; C3H4N2; F.W. 68.08) 
 Add Deionized, dd H20to bring to desired volume 
 Adjust pH to 8.0 using 6M HCl 
 Store at 4ºC 
 
Wash Buffer 
 50 mM Sodium Phosphate (NaH2PO4 · H2O; F.W. 137.99) 
 300 mM NaCL (NaCl; F.W. 58.44) 
 20 mM Imidazole (HNCH:CHN:CH; C3H4N2; F.W. 68.08) 
 10 % (of desired final volume) glycerol  
 Add dd H20 to bring to desired volume 
 Adjust pH to 8.0 using 6M HCl 
 Store at 4ºC 
 
Elution Buffer 
50 mM Sodium Phosphate (NaH2PO4 · H2O; F.W. 137.99) 
 300 mM NaCL (NaCl; F.W. 58.44) 
 300 mM Imidazole (HNCH:CHN:CH; C3H4N2; F.W. 68.08) 
 10% (of desired final volume) glycerol 
 Add dd H20 to bring to desired volume 
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 Adjust pH to 8.0 using 6M HCl 
 Store at 4ºC 
 
2x Loading Buffer 
 2.5 ml of 0.5 M Tris HCl (pH 6.8) 
 2 ml of 10% Glycerol 
 4 ml of 10% SDS 
 1 ml β-marcaptoethanol 
 2 mg Bromophenol Blue 
 0.5 ml dd H20 
  
Procedure 
 
Inoculation 
 
1. Using a plastic inoculation loop, choose a single colony of 
JM109/pQEtri101 from the LB plus Ampicillin agar plate 
 
2. Inoculate colony into 5mL LB Broth with ampillicin (final concentration of 
100 µg/ml)  
 
3. Incubate overnight at 37ºC in a shaking water bath  
 
Induction 
 
4. Pour overnight culture into 50 mL prewarmed (37ºC) LB Ampicillin (final 
concentration of 100 µg/ml) media 
 
5. Incubate culture at 37ºC for 3 hours in a shaking water bath  
 
6. After 3 hours, check the OD using 1 mL of culture media.  Use LB media 
as the blank.  Continue incubation at 37°C until OD ≥0.5 
 
 
7. Remove 2 “pre-induction” 1 mL samples 
a. Microcentrifuge for 1 minute at 13,000 RPM (~16,000 x g) 
b. Pour off supernant 
c. Resuspend pellet in 50 μL 2X loading buffer 
d. Store at -20ºC until SDS PAGE 
 
8. Add 2 mM IPTG (1 mL) to the remaining culture 
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9. Incubate at 37ºC for 3 hours in a shaking water bath  
 
10. After 3 hours, remove 2 - 1mL “post induction” samples 
a. MicroCentrifuge for 1 minute at 13,000 RPM (~16,000 x g) 
b. Pour off supernant 
c. Resuspend pellet in 50 μL 2X loading buffer 
d. Store at -20ºC until SDS PAGE 
 
11. Pour remaining induced culture into 2 centrifuge bottles of equal volumes 
 
12. Centrifuged at 4ºC at 5,000 RPM for 20 minutes (3836 x g) using the 
Beckman Centrifuge 
 
13. Pour off supernant 
 
14. Resuspended 1st pellet using 5 mL 1X PBS (room temperature).  Be sure 
pellet is resuspended completely.  Wash sides of centrifuge bottle.  
Transfer complete solution to the second bottle 
 
15. Resuspend 2nd pellet using same 5mL 1X PBS suspension from bottle one 
 
16. Transfer to 5 ml Polysterene Round Bottom Tube 
 
17. Add 100 μL lysozyme at 50 mg/mL (final concentration 1mg/ml lysozyme) 
 
18. Place on ice for 30 minutes 
 
19. Meanwhile prepared ice/NaCl adding about 100 grams of NaCl to a 200 
ml flask full of ice (this will keep solution extra cold during sonication) 
 
20. Remove suspension from ice and place tube into Ice/NaCl mixture to keep 
cold 
 
Sonication 
 
21. Position sonicator probe into suspension so that it is submerged at least ½ 
inch, ensuring that probe does not touch sides or bottom of tube 
 
22. Sonicate at level 3 for 1 minute  
 
23. Rest for 2 minutes 
 
24. Repeat 4 times (5 total) 
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25. Transfer solution to 30 ml polypropylene centrifuge tube 
 
26. Centrifuge for 30 minutes at 4ºC at 10,000 RPM (15,344 x g) in the 
Beckman Centrifuge 
 
 
Ni NTA Column 
 
27.  The supernant from centrifugication in step 26,  
a. Label tube “Soluable”  
i. Remove 50 µl for SDS PAGE 
ii. Mix with 50 µl of 2x loading buffer 
b. place in -20ºC freezer 
 
28. Resuspend pellet from step 26, in 5 mL lysis buffer 
a. Label as “INSoluable” 
i. Remove 100 µl for SDS PAGE 
ii. Microcentrifuge for 1 minute at 13,000 RPM (16,000 x g) 
iii. Resuspend pellet in 50 µl of 2x loading buffer 
 
29. Add 0.5 mL of 30% Empigen to the insoluable sample or pellet fraction 
 
30. Placed on rocker in 4ºC Isotemp refrigerator overnight  
 
31. The next morning, aliquot into 1 mL fractions and place in 1.5 ml 
microcentrifuge tubes 
 
32. Microcentrifuge for 20 minutes at 13,000 RPM (~16,000 x g) 
 
33. Meanwhile, pre-equilibrate Ni NTA Agarose using Lysis buffer  
a. Combine 1 mL Ni NTA Agarose with ~ 5mL Lysis buffer  
b. Centrifuge at 3000 for 1 minute (~1296 x g) 
c. Withdraw majority of supernant with pastuer pipette and discard (do 
NOT decant supernant, because agarose will pour out too) 
d. Repeat 2 additional times (3 total) 
 
34. After microcentrifugication of insoluabe fraction is complete, there should 
be no pellet.  Pipett all supernant into pre-equilibrated 1 ml Ni NTA 
solution 
 
35. Place on rocking platforrm and mix for 1.5 hours in 4ºC  
 
36. Label 1 mL tubes for elution 1 to 5, wash 1 to 5, and a larger tube for flow 
through 
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37. Label 11 1.5 mL tubes for SDS PAGE samples the same as Step 36.  
Place 50 μL 2X loading buffer in each tube plus (elution fractons 1-5, wash 
fractions 1-5, and flow through) 
 
38. Aliquot 2.5 mL of Elution and Wash buffer into separate, labeled tubes 
 
39. Fill column with lysis buffer  
 
40. Remove tip from column and drain majority of lysis buffer from column.  
Replace tip when finished.  Discard lysis buffer 
 
41. Remove insoluable fraction from rocker 
 
42. Pour the sample with Ni-NTA agarose into column 
 
43. Allow column to settle 
 
a. Ni-Nta agarose will settle to bottom of the column 
b. The lysis buffer and insoluable fraction will float to top 
 
44. Remove tip and collect flow through (Don’t allow all of the lysis buffer 
solution to drain off.  Leave a small amount, between .25 and .5 ml, above 
the agarose) 
 
45. Add 1 mL Wash buffer 
a. Collect 0.3 mL fractions in each of the 5 1 mL centrifuge tubes 
b. Add rest of wash buffer as needed 
c. Don’t allow the column all of the wash buffer solution to drain off.  
Leave a small amount, between .25 and .5 ml, above the agarose 
 
46. Repeat step 45 with 2.5 ml of the aliquoted Elution buffer to acquire the 
isolated protein, rrTri101 
 
47. Pipette 50 μL from each elution, wash, and flow through fraction tubes and 
place in corresponding labeled tubes with 2X loading buffer (Step 37) 
 
48. Store remaining sample tubes at -20ºC until completing SDS PAGE 
 
49. Run SDS PAGE (Appendix J) on samples from the pre-induced sample, 
the post induction sample, the supernant or soluable sample, the pellet or 
insoluable sample, the flow through, each of the 5 wash fractions, and 
each of the 5 eluted fractions. 
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Appendix L 
Pierce Slide-A-Lyzer® Dialysis 
  
Materials 
 
Slide-A-Lyzer Dialysis Cassettes (Pierce 66370, Rockford, IL ) 
Slide-A-Lyzer Buoys (Pierce 66430 Rockford, IL) 
Slide-A-Lyzer Syringe (5 ml) and 18 Gauge Needle Accessories  
(Pierce 66490 Rockford, IL) 
10X PBS (Sigma P5493, St Louis, MO) 
 
Solutions 
 
1X PBS 
Dilute 1 part 10X PBS with 10 parts ddH20 
 
Procedure 
 
1. Thaw rTri101 on ice 
 
2. Remove the Slide-A-Lyzer Dialysis Cassette from its protective pouch by 
cutting along the dotted line. 
 
3. Attach the hub of a hypodermic needle to the Luer-Lok® Fitting of the 
syringe by firmly screwing it into place. 
 
4. Remove the protective sheath from the hypodermic needle and filled 
syringe with rTri101 IB sample by immersing the needle in the sample and 
then slowly drawing back on the syringe piston. 
 
5. Remove cassette from the buoy. Penetrate gasket through one of the 
syringe ports at a corner of the cassette with the needle and inject sample. 
Mark the cassette corner with a permanent marker. 
 
6. With the needle still inserted in the cassette cavity, draw up on the piston 
to remove air from the cavity to compress the membrane so the sample 
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contacts the greatest membrane surface area. Use caution to prevent the 
needle from contacting the membrane. 
 
7. Remove the syringe needle from the cassette while retaining the air in the 
syringe. The gasket reseals and the membrane cavity has no (or minimal) 
air in direct contact with the sample. 
 
8. Slip the cassette into the groove of a buoy and float this assembly in a 
beaker containing 800 ml of 1X PBS to dialyze: 
 
a. Dialyze for 2 hours in 1X PBS at 4°C;  
b. Change the 1X PBS and dialyze for another 2 hours at 4°C; 
c. Change the 1X PBS and dialyze overnight at 4°C.  
d. Use the 800 ml of 1X PBS for each buffer 
 
9. To remove sample, fill syringe with a volume of air at least equal to the 
sample size.  
 
10. Penetrate the gasket with a needle through a top, unused syringe guide 
port. Discharge air into cassette cavity to separate membranes, which 
prevents needle penetration of the membrane. 
 
11. Rotate the Cassette until the port with the syringe is on the bottom and 
slowly draw back on the syringe piston to capture the dialyzed sample.  
Remove the syringe needle from the cassette.  Discard the Slide-A-Lyzer 
Dialysis Cassette. 
 
12.   Store samples as -20°C until ready for BCA protein assay. 
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Appendix M 
Pierce BCA Protein Assay 
 
Materials  
 
Glass tubes (Fisher 14-961-26 Atlanta, GA) 
Smart Spec 3000 Spectrophotometer (Biorad, 170-2501EDU) 
BCA Protein Assay Kit (Pierce 23225, Rockford, IL) contained: 
BCA Reagent A, contained:  sodium carbonate, sodium bicarbonate, 
bicinchoninic acid and sodium tartrate in 0.1 M sodium hydroxide 
BCA Reagent B, contained 4% cupric sulfate 
Albumin Standard Ampules, 2 mg/ml, 10 - 1 ml ampules, containing 
bovine serum albumin (BSA) at 2.0 mg/ml in 0.9% saline and 0.05% 
sodium azide 
 
Procedure: 
 
Preparation of Standards and Working Reagent 
 
A. Preparation of Diluted Albumin (BSA) Standards 
Use Appendix Table 2.1 as a guide to prepare a set of protein standards. 
Use dd H20 to dilute the contents of one Albumin Standard (BSA) ampule 
into several clean vials, preferably using the same diluent as the 
sample(s).  There will be sufficient volume for three replications of each 
diluted standard. 
 
 
B. Preparation of the BCA Working Reagent (WR) 
 
1. Use the following formula to determine the total volume of WR required: 
 
(# standards + # unknowns) × (# replicates) × (volume of WR per sample) = total 
volume WR required 
Example: for the standard test-tube procedure with 3 unknowns and 2 replicates 
of each sample: 
(9 standards + 3 unknowns) × (2 replicates) × (2 ml) = 48 ml WR required 
 
2. Prepare WR by mixing 50 parts of BCA Reagent A with 1 part of BCA Reagent 
B (50:1, Reagent A:B). For the above example, combine 50 ml of Reagent A with 
1 ml of Reagent B. 
 
Appendix Table 2.1 Preparation of Diluted Albumin (BSA) Standards 
Dilution Scheme for Standard Test Tube Protocol and Microplate Procedure 
(Working Range = 20–2,000 μg/ml) 
 
 
Vial Volume   Volume & Source Final BSA  
  
distilled, 
deionized 
H20 of BSA Concentration 
  (μL) (μL) (µg/mL) 
A 0 300 μL Stock 2000 
B 125 375 μL Stock 1500 
C 325 325 μL Stock 1000 
D 175 
175 μL vial B 
dilution 750 
E 325 
325 μL vial C 
dilution 500 
F 325 
325 μL vial E 
dilution 250 
G 325 
325 μL vial F 
dilution 125 
H 400 
100 μL vial G 
dilution 25 
I 400 0 Blank 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: When Reagent B is first added to Reagent A, turbidity is observed that 
quickly disappears upon mixing to yield a clear, green WR. Prepare sufficient 
volume of WR based on the number of samples to be assayed. The WR is stable 
for several days when stored in a closed container at room temperature (RT). 
 
 
Procedure Summary  
 
1. Pipette 0.1 ml of each standard and unknown sample replicate into an 
appropriately labeled test tube. 
 
2. Add 2.0 ml of the WR to each tube and mix well. 
 
3. Cover and incubate tubes at selected temperature and time: 
• 37°C for 30 minutes (working range = 20-2,000 μg/ml) 
 
4. Cool all tubes to room temperature 
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5. With the spectrophotometer set to 562 nm, zero the instrument on a cuvette 
filled only with water. Subsequently, measure the absorbance of all the samples 
within 10 minutes. 
 
6. Subtract the average 562 nm absorbance measurement of the Blank standard 
replicates from the 562 nm absorbance measurement of all other individual 
standard and unknown sample replicates. 
 
7. Prepare a standard curve by plotting the average Blank-corrected 562 nm 
measurement for each BSA standard vs. its concentration in μg/ml. Use the 
standard curve to determine the protein concentration of each unknown sample. 
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Appendix N 
Purification of rTri101 from soluble fractions 
 
Use materials and solutions recipes from Appendix K with the following changes 
to the procedure: 
Procedure 
Inoculation 
 
1.  Using a plastic inoculation loop, choose a single colony of 
JM109/pQEtri101 from the LB plus Ampicillin agar plate 
 
2.  Inoculate colony into 5mL LB Broth with ampillicin (final concentration of 
100 µg/ml)  
 
3. Incubate overnight at 37ºC in a shaking water bath  
 
 
Induction 
 
4. Inoculate overnight culture into 50 mL prewarmed (37ºC)  LB  Ampicillin 
(final concentration of 100 µg/ml) media 
 
5. Incubate culture at 37ºC for 3 hours in a shaking water bath  
 
6. After 3 hours, check the OD using 1 mL of culture media.  Use LB media 
as the blank.  Continue incubation at 37°C until OD ≥0.5 
 
7. Remove 2 “pre-induction” 1 mL samples 
a. Microcentrifuge for 1 minute at 13,000 RPM (~16,000 x g) 
b. Pour off supernant 
c. Resuspend pellet in 50 μL 2X loading buffer 
d. Store at -20ºC until SDS PAGE 
 
8. Add 1 mM IPTG (0.5 mL) to the remaining culture 
 
9. Incubate at 37ºC for 2 hours in a shaking water bath  
 
10. After 2 hours, remove 2 - 1mL “post induction” samples 
a. MicroCentrifuge for 1 minute at 13,000 RPM (~16,000 x g) 
b. Pour off supernant 
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c. Resuspend pellet in 50 μL 2X loading buffer 
d. Store at -20ºC until SDS PAGE 
 
11. Pour remaining induced culture into 2 centrifuge bottles of equal volumes 
 
12. Centrifuged at 4ºC at 5,000 RPM for 20 minutes (3836 x g) using the 
Beckman Centrifuge 
 
13. Pour off supernant 
 
14. Resuspended 1st pellet using 5 mL 1X PBS (room temperature).  Be sure 
pellet is resuspended completely.  Wash sides of centrifuge bottle.  
Transfer complete solution to the second bottle 
 
15. Resuspend 2nd pellet using same 5mL 1X PBS suspension from bottle one 
 
16. Transfer to 5 ml Polysterene Round Bottom Tube 
 
17. Place on ice for 30 minutes (do not add any lysozyme) 
 
18. Meanwhile prepared ice/NaCl adding about 100 grams of NaCl to a 200 
ml flask full of ice (this will keep solution extra coldl during sonication) 
 
19. Remove suspension from ice and place tube into Ice/NaCl mixture to keep 
cold 
 
Sonication  
20.  Position sonicator probe into suspension so that it is submerged at least 
½ inch, ensuring that probe does not touch sides or bottom of tube 
 
21. Sonicate at level 3 for 1 minute  
 
22. Rest for 2 minutes 
 
23. Repeat 4 times (5 total) 
 
24. Transfer solution to 30 ml polypropylene centrifuge tube 
 
25. Centrifuge for 30 minutes at 4ºC at 10,000 RPM (15,344 x g) in the 
Beckman Centrifuge 
 
26.  For the supernant from centrifugication in step 25,  
a.  Label tube “Soluable”  
i. Remove 50 µl for SDS PAGE 
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ii. Mix with 50 µl of 2x loading buffer 
 
27. For the pellet from step 25,  
a. Resuspend pellet in 5 mL lysis buffer 
b. Label as “INSoluable” 
i. Remove 100 µl for SDS PAGE 
ii. Microcentrifuge for 1 minute at 13,000 RPM (16,000 x g) 
iii. Resuspend pellet in 50 µl of 2x loading buffer 
c. Store in -20ºC freezer 
 
Ni NTA Column  
28.  Thaw supernant (soluble fraction) on ice 
 
29. Aliquot into 1 mL fractions and place in 1.5 ml microcentrifuge tubes 
 
30. Microcentrifuge for 20 minutes at 13,000 RPM (~16,000 x g) 
 
31. Meanwhile, pre-equilibrate Ni NTA Agarose using Lysis buffer  
a. Combine 1 mL Ni NTA Agarose with ~ 5mL Lysis buffer  
b. Centrifuge at 3000 for 1 minute (~1296 x g) 
c. Withdraw majority of supernant with pastuer pipette and discard (do 
NOT decant supernant, because agarose will pour out too) 
d. Repeat 2 additional times (3 total) 
 
32. After microcentrifugation of soluble fraction is complete, there should be 
no pellet.  Pipette all supernant into pre-equilibrated 1 ml Ni NTA solution 
 
33. Place on rocking platform and mix for 1.5 hours in 4ºC  
 
34. Label 1 mL tubes for elution 1 to 5, wash 1 to 5, and a larger, 15 ml tube 
for flow through 
 
35. Label 11 1.5 mL tubes for SDS PAGE samples the same as step 34.  
Place 50 μL 2X loading buffer in each tube plus (elution fractions 1-5, 
wash fractions 1-5, and flow through) 
 
36. Aliquot 2.5 mL of Elution and Wash buffer into separate, labeled tubes 
 
37. Fill column with lysis buffer  
 
38. Remove tip from column and drain majority of lysis buffer from column.  
Replace tip when finished.  Discard lysis buffer 
 
39. Remove soluble fraction with Ni-NTA agarose from rocker 
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40. Pour the sample with Ni-NTA agarose into column 
 
41. Allow column to settle (wait 1 to 3 minutes) 
 
a. Ni-NTA agarose will settle to bottom of the column 
b. The lysis buffer and soluable fraction will float to top 
 
42. Remove tip and collect flow through (Don’t allow all of the lysis buffer 
solution to drain off.  Leave a small amount, between .25 and .5 ml, above 
the agarose) 
 
43. Add 1 mL Wash buffer 
a. Collect 0.3 mL fractions in each of the 5 1 mL centrifuge tubes 
b. Add rest of wash buffer as needed 
c. Don’t allow the column all of the wash buffer solution to drain off.  
Leave a small amount, between .25 and .5 ml, above the agarose 
 
44. Repeat step 43 with 2.5 ml of the aliquoted Elution buffer to acquire the 
isolated protein, rrTri101 
 
45. Pipette 50 μL from each elution, wash, and flow through fraction tubes and 
place in corresponding labeled tubes with 2X loading buffer (Step 35) 
 
46. Store remaining sample tubes at -20ºC until completing SDS PAGE 
 
47. Run SDS PAGE (Appendix J) on samples from the pre-induced sample, 
the post induction sample, the supernant or soluable sample, the pellet or 
insoluable sample, the flow through, each of the 5 wash fractions, and 
each of the 5 eluted fractions. 
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Appendix O 
Production of Crude rTri101 
 
Use materials and solutions recipes from Appendix K with the following changes 
to the procedure: 
 
Inoculation  
 
1.  Using a plastic inoculation loop, choose a single colony of 
JM109/pQEtri101 from the LB plus Ampicillin agar plate 
 
2.  Inoculate colony into 5mL LB Broth with ampillicin (final concentration of 
100 µg/ml)  
 
3. Incubate overnight at 37ºC in a shaking water bath  
 
 
Induction 
 
4. Inoculated overnight culture into 50 mL prewarmed (37ºC)  LB  Ampicillin 
(final concentration of 100 µg/ml) media 
 
5. Incubate culture at 37ºC for 3 hours in a shaking water bath  
 
6. After 3 hours, check the OD using 1 mL of culture media.  Use LB media 
as the blank.  Continue incubation at 37°C until OD ≥0.5 
 
7. Remove 2 “pre-induction” 1 mL samples 
a. Microcentrifuge for 1 minute at 13,000 RPM (~16,000 x g) 
b. Pour off supernant 
c. Resuspend pellet in 50 μL 2X loading buffer 
d. Store at -20ºC until SDS PAGE 
 
8. Add 1 mM IPTG (0.5 mL) to the remaining culture 
 
9. Incubate at 37ºC for 2 hours in a shaking water bath  
 
10. After 2 hours, remove 2 - 1mL “post induction” samples 
a. MicroCentrifuge for 1 minute at 13,000 RPM (~16,000 x g) 
b. Pour off supernant 
c. Resuspend pellet in 50 μL 2X loading buffer 
d. Store at -20ºC until SDS PAGE 
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11. Pour remaining induced culture into 2 centrifuge bottles of equal volumes 
 
12. Centrifuged at 4ºC at 5,000 RPM for 20 minutes (3836 x g) using the 
Beckman Centrifuge 
 
13. Pour off supernant 
 
14. Resuspended 1st pellet using 5 mL 1X PBS (room temperature).  Be sure 
pellet is resuspended completely.  Wash sides of centrifuge bottle.  
Transfer complete solution to the second bottle 
 
15. Resuspend 2nd pellet using same 5mL 1X PBS suspension from bottle one 
 
16. Transfer to 5 ml Polysterene Round Bottom Tube 
 
17. Add 100 μL lysozyme at 50 mg/mL (final concentration 1mg/ml lysozyme) 
 
18. Place on ice for 30 minutes 
 
19. Meanwhile prepared ice/NaCl adding about 100 grams of NaCl to a 200 
ml flask full of ice (this will keep solution extra coldl during sonication) 
 
20. Remove suspension from ice and place tube into Ice/NaCl mixture to keep 
cold 
 
Sonication  
 
21. Position sonicator probe into suspension so that it is submerged at least ½ 
inch, ensuring that probe does not touch sides or bottom of tube 
 
22. Sonicate at level 3 for 1 minute  
 
23. Rest for 2 minutes 
 
24. Repeat 4 times (5 total) 
 
25. Transfer solution to 30 ml polypropylene centrifuge tube 
 
26. Centrifuge for 30 minutes at 4ºC at 10,000 RPM (15,344 x g) in the 
Beckman Centrifuge 
 
27.  The supernant from centrifugication in step 26,  
a. Label tube “Soluable”  
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i. Remove 50 µl for SDS PAGE 
ii. Mix with 50 µl of 2x loading buffer 
b. place in -20ºC freezer 
 
28. Resuspend pellet from step 26, in 5 mL lysis buffer 
a. Label as “INSoluable” 
i. Remove 100 µl for SDS PAGE 
ii. Microcentrifuge for 1 minute at 13,000 RPM (16,000 x g) 
iii. Resuspend pellet in 50 µl of 2x loading buffer 
 
29. Store remaining sample tubes at -20ºC until completing SDS PAGE 
 
30. Run SDS PAGE (Appendix J) on samples from the pre-induced sample, 
the post induction sample, the supernant or soluable sample, and the 
pellet or insoluable sample. 
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